BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Akhmerov A, Marbán E. COVID-19 and the Heart. Circ Res 2020;126:1443-55. [PMID: 32252591 DOI: 10.1161/CIRCRESAHA.120.317055] [Cited by in Crossref: 434] [Cited by in F6Publishing: 461] [Article Influence: 144.7] [Reference Citation Analysis]
Number Citing Articles
1 Kite TA, Pallikadavath S, Gale CP, Curzen N, Ladwiniec A. The Direct and Indirect Effects of COVID-19 on Acute Coronary Syndromes. Heart Fail Clin 2023;19:185-96. [PMID: 36863810 DOI: 10.1016/j.hfc.2022.08.002] [Reference Citation Analysis]
2 Kumari K, Nandi A, Sinha A, Ghosh A, Sengupta S, Saha U, Singh PK, Panda PK, Raina V, Verma SK. The paradigm of prophylactic viral outbreaks measures by microbial biosurfactants. J Infect Public Health 2023;16:575-87. [PMID: 36840992 DOI: 10.1016/j.jiph.2023.02.016] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Stotts C, Corrales-Medina VF, Rayner KJ. Pneumonia-Induced Inflammation, Resolution and Cardiovascular Disease: Causes, Consequences and Clinical Opportunities. Circ Res 2023;132:751-74. [PMID: 36927184 DOI: 10.1161/CIRCRESAHA.122.321636] [Reference Citation Analysis]
4 Pannucci P, Jefferson SR, Hampshire J, Cooper SL, Hill SJ, Woolard J. COVID-19-Induced Myocarditis: Pathophysiological Roles of ACE2 and Toll-like Receptors. IJMS 2023;24:5374. [DOI: 10.3390/ijms24065374] [Reference Citation Analysis]
5 Purbey PK, Roy K, Gupta S, Paul MK. Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2. Mol Immunol 2023;156:111-26. [PMID: 36921486 DOI: 10.1016/j.molimm.2023.03.009] [Reference Citation Analysis]
6 Shahid R, Jin J, Hope K, Tunuguntla H, Amdani S. Pediatric Pericarditis: Update. Curr Cardiol Rep 2023;25:157-70. [PMID: 36749541 DOI: 10.1007/s11886-023-01839-0] [Reference Citation Analysis]
7 Nadi A, Shiravi AA, Mohammadi Z, Aslani A, Zeinalian M. Thymus vulgaris, a natural pharmacy against COVID-19: A molecular review. J Herb Med 2023;38:100635. [PMID: 36718131 DOI: 10.1016/j.hermed.2023.100635] [Reference Citation Analysis]
8 Uhl B, Haring F, Slotta-Huspenina J, Luft J, Schneewind V, Hildinger J, Wu Z, Steiger K, Smiljanov B, Batcha AMN, Keppler OT, Hellmuth JC, Lahmer T, Stock K, Weiss BG, Canis M, Stark K, Bromberger T, Moser M, Schulz C, Weichert W, Zuchtriegel G, Reichel CA. Vitronectin promotes immunothrombotic dysregulation in the venular microvasculature. Front Immunol 2023;14:1078005. [PMID: 36845099 DOI: 10.3389/fimmu.2023.1078005] [Reference Citation Analysis]
9 Wang L, Volkow ND, Berger NA, Davis PB, Kaelber DC, Xu R. Association of COVID-19 with endocarditis in patients with cocaine or opioid use disorders in the US. Mol Psychiatry 2023;28:543-52. [PMID: 36510003 DOI: 10.1038/s41380-022-01903-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Roca-Fernandez A, Wamil M, Telford A, Carapella V, Borlotti A, Monteiro D, Thomaides-Brears H, Kelly M, Dennis A, Banerjee R, Robson M, Brady M, Lip GYH, Bull S, Heightman M, Ntusi N, Banerjee A. Cardiac abnormalities in Long COVID 1-year post-SARS-CoV-2 infection. Open Heart 2023;10. [PMID: 36822818 DOI: 10.1136/openhrt-2022-002241] [Reference Citation Analysis]
11 Farkas D, Bogamuwa S, Piper B, Newcomb G, Gunturu P, Bednash JS, Londino JD, Elhance A, Nho R, Mejia OR, Yount JS, Horowitz JC, Goncharova EA, Mallampalli RK, Robinson RT, Farkas L. A role for Toll-like receptor 3 in lung vascular remodeling associated with SARS-CoV-2 infection. bioRxiv 2023:2023. [PMID: 36747676 DOI: 10.1101/2023.01.25.524586] [Reference Citation Analysis]
12 De A, Bansal M. Clinical profile and the extent of residual myocardial dysfunction among patients with previous coronavirus disease 2019. Int J Cardiovasc Imaging 2023;:1-8. [PMID: 36607468 DOI: 10.1007/s10554-022-02787-6] [Reference Citation Analysis]
13 Naeem M, Bano N, Manzoor S, Ahmad A, Munawar N, Razak SIA, Lee TY, Devaraj S, Hazafa A. Pathogenetic Mechanisms of Liver-Associated Injuries, Management, and Current Challenges in COVID-19 Patients. Biomolecules 2023;13. [PMID: 36671484 DOI: 10.3390/biom13010099] [Reference Citation Analysis]
14 Laino ME, Ammirabile A, Motta F, De Santis M, Savevski V, Francone M, Chiti A, Mannelli L, Selmi C, Monti L. Advanced Imaging Supports the Mechanistic Role of Autoimmunity and Plaque Rupture in COVID-19 Heart Involvement. Clin Rev Allergy Immunol 2023;64:75-89. [PMID: 35089505 DOI: 10.1007/s12016-022-08925-1] [Reference Citation Analysis]
15 Eskandari D, Ziaee A, Amirfarhangi Anbardan A, Zeinali E, Tirkan A. Primary adrenal insufficiency and myocarditis in COVID-19 disease: a case report. BMC Endocr Disord 2022;22:336. [PMID: 36587233 DOI: 10.1186/s12902-022-01257-3] [Reference Citation Analysis]
16 Samper-Pardo M, León-Herrera S, Oliván-Blázquez B, Benedé-Azagra B, Magallón-Botaya R, Gómez-Soria I, Calatayud E, Aguilar-Latorre A, Méndez-López F, Pérez-Palomares S, Cobos-Rincón A, Valero-Errazu D, Sagarra-Romero L, Sánchez-Recio R. Development and Validation of a Mobile Application as an Adjuvant Treatment for People Diagnosed with Long COVID-19: Protocol for a Co-Creation Study of a Health Asset and an Analysis of Its Effectiveness and Cost-Effectiveness. Int J Environ Res Public Health 2022;20. [PMID: 36612782 DOI: 10.3390/ijerph20010462] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Aragón-Benedí C, Caballero-Lozada AF, Perez-Calatayud AA, Marulanda-Yanten AM, Oliver-Fornies P, Boselli E, De Jonckheere J, Bergese SD; ANI-COVID-19 Research Group. Prospective multicenter study of heart rate variability with ANI monitor as predictor of mortality in critically ill patients with COVID-19. Sci Rep 2022;12:21762. [PMID: 36526646 DOI: 10.1038/s41598-022-25537-z] [Reference Citation Analysis]
18 Kahe Z, Pasebani Y, Rafati A, Salimi N, Rezaei Y, Rahnamun Z, Mousavi N, Haghighattalab AV, Sharifi F, Samiei N. Alteration in follow-up echocardiographic indices in patients with COVID-19: a prospective cohort study.. [DOI: 10.21203/rs.3.rs-2340932/v1] [Reference Citation Analysis]
19 Octavius GS, Wijaya JH, Tan AO, Muljono MP, Chandra S, Juliansen A. Autopsy findings of pediatric COVID-19: a systematic review. Egypt J Forensic Sci 2022;12. [DOI: 10.1186/s41935-022-00288-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Efgan MG, Çinaroğlu OS, Payza U, Kanter E, Cebeci BD. Common ECG Changes and Prognostic Importance of ECG Findings in Covid-19 Patients Presenting to the Emergency Department. J Contemp Med 2022;12:966-972. [DOI: 10.16899/jcm.1197111] [Reference Citation Analysis]
21 Ilyicheva TN, Netesov SV, Abubakirova OA, Gureyev VN. Respiratory viral infections and their role in human cardiovascular diseases. SJCEM 2022;37:14-21. [DOI: 10.29001/2073-8552-2022-37-4-14-21] [Reference Citation Analysis]
22 Ilyicheva TN, Netesov SV, Abubakirova OA, Gureyev VN. Respiratory viral infections and their role in human cardiovascular diseases. SJCEM 2022. [DOI: 10.29001/2073-8552-2022-418] [Reference Citation Analysis]
23 Pushparaj TL, Irudaya Raj EF, Irudaya Rani EF. A detailed review of contrast-enhanced fluorescence magnetic resonance imaging techniques for earlier prediction and easy detection of COVID-19. Computer Methods in Biomechanics and Biomedical Engineering: Imaging & Visualization 2022. [DOI: 10.1080/21681163.2022.2144762] [Reference Citation Analysis]
24 Madaschi S, Resmini E, Bonfadini S, Massari G, Gamba P, Sandri M, Calza S, Cimino E, Zarra E, Dotti S, Mascadri C, Agosti B, Garrafa E, Girelli A. Predictive markers for clinical outcomes in a cohort of diabetic patients hospitalized for COVID-19. Diabetol Metab Syndr 2022;14:168. [DOI: 10.1186/s13098-022-00941-7] [Reference Citation Analysis]
25 Abdelmissih S. A Bitter Experience That Enlightens the Future: COVID-19 Neurological Affection and Perspectives on the Orexigenic System. Cureus 2022. [DOI: 10.7759/cureus.30788] [Reference Citation Analysis]
26 Qiao J, Zhao P, Lu J, Huang L, Ma X, Zhou X, Xia L. Cardiac involvement in patients 1 year after recovery from moderate and severe COVID-19 infections. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.1009637] [Reference Citation Analysis]
27 Sun Y, Zou Y, Wang H, Cui G, Yu Z, Ren Z. Immune response induced by novel coronavirus infection. Front Cell Infect Microbiol 2022;12. [DOI: 10.3389/fcimb.2022.988604] [Reference Citation Analysis]
28 Moreno-perez O, Nuñez J, Sandin-rollan M, Arrarte V, Boix V, Reus S, Pinargote-celorio H, Ribes I, Alfayate R, Llorca-santos MB, Martinez-garcia MA, Chico-sánchez P, Merino E. Early carbohydrate antigen 125 as a mortality predictor in hospitalized patients with coronavirus disease 2019. Front Cardiovasc Med 2022;9:941512. [DOI: 10.3389/fcvm.2022.941512] [Reference Citation Analysis]
29 Xu Z, Zou Y, Gao X, Niu M, Li J, Xue L, Jiang S. Dual-targeting cyclic peptides of receptor-binding domain (RBD) and main protease (Mpro) as potential drug leads for the treatment of SARS-CoV-2 infection. Front Pharmacol 2022;13:1041331. [DOI: 10.3389/fphar.2022.1041331] [Reference Citation Analysis]
30 Chamtouri I, Kaddoussi R, Abroug H, Abdelaaly M, Lassoued T, Fahem N, Cheikh'hmad S, Ben Abdallah A, Jomaa W, Ben Hamda K, Maatouk F. Mid-term subclinical myocardial injury detection in patients who recovered from COVID-19 according to pulmonary lesion severity. Front Cardiovasc Med 2022;9:950334. [DOI: 10.3389/fcvm.2022.950334] [Reference Citation Analysis]
31 Prameswari HS, Putra ICS, Raffaello WM, Nathaniel M, Suhendro AS, Khalid AF, Pranata R. Managing Covid-19 in patients with heart failure: current status and future prospects. Expert Rev Cardiovasc Ther 2022. [PMID: 36185009 DOI: 10.1080/14779072.2022.2132230] [Reference Citation Analysis]
32 Sarangi MK, Padhi S, Patel LD, Rath G, Nanda SS, Yi DK. Theranostic efficiency of biosurfactants against COVID-19 and similar viruses - A review. J Drug Deliv Sci Technol 2022;76:103764. [PMID: 36090183 DOI: 10.1016/j.jddst.2022.103764] [Reference Citation Analysis]
33 Contreras-Briceño F, Espinosa-Ramírez M, Rozenberg D, Reid WD. Eccentric Training in Pulmonary Rehabilitation of Post-COVID-19 Patients: An Alternative for Improving the Functional Capacity, Inflammation, and Oxidative Stress. Biology (Basel) 2022;11:1446. [PMID: 36290350 DOI: 10.3390/biology11101446] [Reference Citation Analysis]
34 Chen J, Wang Y, Wang J, Chen L, Luo Q, Wang B, He X, Li X, Zuo H, Zuo P, Yang X. Coronavirus disease 2019 death prediction by electrocardiographic abnormalities and elevated D-dimer levels. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.948347] [Reference Citation Analysis]
35 Özer S, Bulut E, Aydin E, Haznedar Kirci DC, Özyildiz AG, Peker M, Turan OE. COVID-19 Hastalarında Mitral Anüler Kalsifikasyonun Mortalite ve Miyokard Hasarı ile İlişkisi. Sakarya Medical Journal 2022. [DOI: 10.31832/smj.1126067] [Reference Citation Analysis]
36 Jusic A, Stellos K, Ferreira L, Baker AH, Devaux Y. (Epi)transcriptomics in cardiovascular and neurological complications of COVID-19. J Mol Cell Cardiol Plus 2022;1:100013. [PMID: 36164464 DOI: 10.1016/j.jmccpl.2022.100013] [Reference Citation Analysis]
37 Hussain MS, Sharma G. The Burden of Cardiovascular Diseases Due to COVID-19 Pandemic. Thorac Cardiovasc Surg. [DOI: 10.1055/s-0042-1755205] [Reference Citation Analysis]
38 Lorusso R, De Piero ME, Mariani S, Ravaux JM, Nardelli P, Jacobs JP, Guarracino F, Patroniti N, Bussel BCV, Horst ICVD, Taccone FS, Heinsar S, Shekar K, Yamashita M, Obonyo NG, Ciullo AL, Brio JRD, Dalton H, Wang A, Zaaqoq AM, Maclaren G, Ramanathan K, Suen JY, Bassi GL, Sato K, Fraser JF, Peek GJ, Arora RC, COVID-19 Critical Care Consortium (CCC) Cardio/ECMOCard. Hemodynamic Monitoring during Veno-Venous Extracorporeal Membrane Oxygenation: A scoping review.. [DOI: 10.21203/rs.3.rs-1943963/v1] [Reference Citation Analysis]
39 Dahmen A, Keller FM, Derksen C, Rinn R, Becker P, Lippke S. Screening and assessment for post-acute COVID-19 syndrome (PACS), guidance by personal pilots and support with individual digital trainings within intersectoral care: a study protocol of a randomized controlled trial. BMC Infect Dis 2022;22:693. [PMID: 35971066 DOI: 10.1186/s12879-022-07584-z] [Reference Citation Analysis]
40 Pandrea I, Brooks K, Desai RP, Tare M, Brenchley JM, Apetrei C. I’ve looked at gut from both sides now: Gastrointestinal tract involvement in the pathogenesis of SARS-CoV-2 and HIV/SIV infections. Front Immunol 2022;13:899559. [DOI: 10.3389/fimmu.2022.899559] [Reference Citation Analysis]
41 Hanson PJ, Liu-Fei F, Ng C, Minato TA, Lai C, Hossain AR, Chan R, Grewal B, Singhera G, Rai H, Hirota J, Anderson DR, Radio SJ, McManus BM. Characterization of COVID-19-associated cardiac injury: evidence for a multifactorial disease in an autopsy cohort. Lab Invest 2022;102:814-25. [PMID: 35437316 DOI: 10.1038/s41374-022-00783-x] [Reference Citation Analysis]
42 Xu S, Zhao X, Xing H, Wu W, Zhang S. Cardiac Involvement in COVID-19: A Global Bibliometric and Visualized Analysis. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.955237] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Akhmerov A, Parimon T. Extracellular Vesicles, Inflammation, and Cardiovascular Disease. Cells 2022;11:2229. [DOI: 10.3390/cells11142229] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Santos MO, Gonçalves LC, Silva PAN, Moreira ALE, Ito CRM, Peixoto FAO, Wastowski IJ, Carneiro LC, Avelino MAG. Multisystem inflammatory syndrome (MIS-C): a systematic review and meta-analysis of clinical characteristics, treatment, and outcomes. J Pediatr (Rio J) 2022;98:338-49. [PMID: 34863701 DOI: 10.1016/j.jped.2021.08.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 4] [Article Influence: 22.0] [Reference Citation Analysis]
45 Wolters AEP, Wolters AJP, van Kraaij TDA, Kietselaer BLJH. Echocardiographic estimation of pulmonary hypertension in COVID-19 patients. Neth Heart J 2022. [PMID: 35771380 DOI: 10.1007/s12471-022-01702-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Xue Y, Yang D, Vogel P, Stabenow J, Zalduondo L, Kong Y, Ravi Y, Sai-sudhakar CB, Parvathareddy J, Hayes E, Taylor S, Fitzpatrick E, Jonsson CB. Cardiopulmonary Injury in the Syrian Hamster Model of COVID-19. Viruses 2022;14:1403. [DOI: 10.3390/v14071403] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Nuzzi V, Del Mestre E, Degrassi A, Bromage DI, Manca P, Piper S, Artico J, Gentile P, Scott PA, Chiatto M, Merlo M, Pareek N, Giacca M, Sinagra G, McDonagh TA, Cannata A. Cardiovascular Damage in COVID-19: What We Know Two Years Later. Curr Cardiol Rep 2022. [PMID: 35751835 DOI: 10.1007/s11886-022-01730-4] [Reference Citation Analysis]
48 Sukmarova ZN, Ibragimova FM, Afonina OV, Simonenko VB. Recurrent course of post-inflammatory cardiopathy: lessons from past epidemics. jour 2022;100:97-107. [DOI: 10.30629/0023-2149-2022-100-2-3-97-107] [Reference Citation Analysis]
49 Arroyo-Rodríguez C, Victoria-Nandayapa JR, López-Aceves M, Machain-Leyva CZ, Soto-Gaxiola AH, Pérez-Méndez FM, Navarro-Ruiz JE, García-Gámez GE, Jacobo-López S, Victoria-Nandayapa V. Takotsubo syndrome in COVID-19: a case series study. Echocardiography 2022. [PMID: 35733395 DOI: 10.1111/echo.15398] [Reference Citation Analysis]
50 Lee SH, Jeong YS, Kim C, Hong J, Sohn S, Park H. Malignant cerebral infarction after COVID-19 myocarditis in 22-year-old female: a case report. J Neurocrit Care 2022;15:65-68. [DOI: 10.18700/jnc.220049] [Reference Citation Analysis]
51 Rudiansyah M, Jasim SA, Mohammad Pour ZG, Athar SS, Jeda AS, Doewes RI, Jalil AT, Bokov DO, Mustafa YF, Noroozbeygi M, Karampoor S, Mirzaei R. Coronavirus disease 2019 (COVID-19) update: From metabolic reprogramming to immunometabolism. J Med Virol 2022. [PMID: 35689351 DOI: 10.1002/jmv.27929] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
52 Gewarges M, Amad H, Luk A. From Bedside to Balloon: The Challenges of In-Hospital ST-Elevation Myocardial Infarction. Circ Cardiovasc Qual Outcomes 2022;15:e008688. [PMID: 35698972 DOI: 10.1161/CIRCOUTCOMES.121.008688] [Reference Citation Analysis]
53 Guimond SE, Mycroft-West CJ, Gandhi NS, Tree JA, Le TT, Spalluto CM, Humbert MV, Buttigieg KR, Coombes N, Elmore MJ, Wand M, Nyström K, Said J, Setoh YX, Amarilla AA, Modhiran N, Sng JDJ, Chhabra M, Young PR, Rawle DJ, Lima MA, Yates EA, Karlsson R, Miller RL, Chen YH, Bagdonaite I, Yang Z, Stewart J, Nguyen D, Laidlaw S, Hammond E, Dredge K, Wilkinson TMA, Watterson D, Khromykh AA, Suhrbier A, Carroll MW, Trybala E, Bergström T, Ferro V, Skidmore MA, Turnbull JE. Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 Interaction. ACS Cent Sci 2022;8:527-45. [PMID: 35647275 DOI: 10.1021/acscentsci.1c01293] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
54 Öncül M, Karakurt C, Elkıran Ö, Bağ HGG. Congenital Heart Disease and COVID-19: A Single-Center Experience. Iran J Pediatr 2022;32. [DOI: 10.5812/ijp-120978] [Reference Citation Analysis]
55 Charfeddine S, Ibnhadjamor H, Jdidi J, Torjmen S, Kraiem S, Bahloul A, Makni A, Kallel N, Moussa N, Boudaya M, Touil I, Ghrab A, Elghoul J, Meddeb Z, Thabet Y, Ben Salem K, Addad F, Bouslama K, Milouchi S, Hammami R, Abdessalem S, Abid L. Sulodexide Significantly Improves Endothelial Dysfunction and Alleviates Chest Pain and Palpitations in Patients With Long-COVID-19: Insights From TUN-EndCOV Study. Front Cardiovasc Med 2022;9:866113. [DOI: 10.3389/fcvm.2022.866113] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
56 Cui N, Jiang C, Yang C, Zhang L, Feng X. Comparison of deep vein thrombosis risks in acute respiratory distress syndrome caused by COVID-19 and bacterial pneumonia: a retrospective cohort study. Thromb J 2022;20:27. [PMID: 35538488 DOI: 10.1186/s12959-022-00386-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
57 Benlier N, Gundogdu N, Ozkur M. Human Genetic Polymorphisms Associated with Susceptibility to COVID-19 Infection and Response to Treatment. Genetic Polymorphisms - New Insights 2022. [DOI: 10.5772/intechopen.99877] [Reference Citation Analysis]
58 Shakerian B, Jebelli M, Mandegar MH. A Very Rare Case of Isolated Spontaneous Pneumopericardium Secondary to COVID-19. Clin Med Insights Case Rep 2022;15:11795476221093290. [PMID: 35465625 DOI: 10.1177/11795476221093290] [Reference Citation Analysis]
59 Eslamian L, Ghalandarpoor-Attar SN, Shabani A, Ghalandarpoor-Attar SM. An unusual clinical manifestation of coronavirus disease 2019 in a woman with twin pregnancy: a case report. J Med Case Rep 2022;16:156. [PMID: 35440094 DOI: 10.1186/s13256-022-03377-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Ammirati E, Lupi L, Palazzini M, Hendren NS, Grodin JL, Cannistraci CV, Schmidt M, Hekimian G, Peretto G, Bochaton T, Hayek A, Piriou N, Leonardi S, Guida S, Turco A, Sala S, Uribarri A, Van de Heyning CM, Mapelli M, Campodonico J, Pedrotti P, Barrionuevo Sánchez MI, Ariza Sole A, Marini M, Matassini MV, Vourc'h M, Cannatà A, Bromage DI, Briguglia D, Salamanca J, Diez-Villanueva P, Lehtonen J, Huang F, Russel S, Soriano F, Turrini F, Cipriani M, Bramerio M, Di Pasquale M, Grosu A, Senni M, Farina D, Agostoni P, Rizzo S, De Gaspari M, Marzo F, Duran JM, Adler ED, Giannattasio C, Basso C, McDonagh T, Kerneis M, Combes A, Camici PG, de Lemos JA, Metra M. Prevalence, Characteristics, and Outcomes of COVID-19-Associated Acute Myocarditis. Circulation 2022;145:1123-39. [PMID: 35404682 DOI: 10.1161/CIRCULATIONAHA.121.056817] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
61 Munipalli B, Seim L, Dawson NL, Knight D, Dabrh AMA. Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management. SN Compr Clin Med 2022;4:90. [PMID: 35402784 DOI: 10.1007/s42399-022-01167-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
62 Perła-kaján J, Jakubowski H. COVID-19 and One-Carbon Metabolism. IJMS 2022;23:4181. [DOI: 10.3390/ijms23084181] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
63 Bhatti H, Cordova Sanchez A, Dhungana R, Carvounis C, Singh A. Left Ventricular Global Longitudinal Strain in Patients With COVID-19 Infection. Cureus 2022. [DOI: 10.7759/cureus.23986] [Reference Citation Analysis]
64 Li S, Wang J, Yan Y, Zhang Z, Gong W, Nie S. Clinical Characterization and Possible Pathological Mechanism of Acute Myocardial Injury in COVID-19. Front Cardiovasc Med 2022;9:862571. [PMID: 35387441 DOI: 10.3389/fcvm.2022.862571] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
65 Ismayl M, Butt DN, Balakrishna AM, Kousa O, Kabach A. COVID-19 presenting with myocardial infarction with nonobstructive coronary arteries. Baylor University Medical Center Proceedings. [DOI: 10.1080/08998280.2022.2057158] [Reference Citation Analysis]
66 Ceccarini G, Gilio D, Magno S, Pelosini C, Leverone M, Miceli C, Barison A, Fabiani I, Emdin M, Santini F. Post-acute cardiac complications following SARS-CoV-2 infection in partial lipodystrophy due to LMNA gene p.R349W mutation. J Endocrinol Invest 2022. [PMID: 35384599 DOI: 10.1007/s40618-022-01795-6] [Reference Citation Analysis]
67 Roca-fernández A, Wamil M, Telford A, Carapella V, Borlotti A, Monteiro D, Thomaides-brears H, Kelly MD, Dennis A, Banerjee R, Robson MD, Brady M, Lip GYH, Bull S, Heightman M, Ntusi N, Banerjee A. Cardiac impairment in Long Covid 1-year post-SARS-CoV-2 infection.. [DOI: 10.1101/2022.04.03.22272610] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Gomez JMD, Zimmerman AC, du Fay de Lavallaz J, Wagner J, Tung L, Bouroukas A, Nguyen TTP, Canzolino J, Goldberg A, Santos Volgman A, Suboc T, Rao AK. Echocardiographic predictors of mortality and morbidity in COVID-19 disease using focused cardiovascular ultrasound. IJC Heart & Vasculature 2022;39:100982. [DOI: 10.1016/j.ijcha.2022.100982] [Reference Citation Analysis]
69 Gonzalez FA, Ângelo-Dias M, Martins C, Gomes R, Bacariza J, Fernandes A, Borrego LM, EchoCrit Group. Characteristic Immune Dynamics in COVID-19 Patients with Cardiac Dysfunction. J Clin Med 2022;11. [PMID: 35407485 DOI: 10.3390/jcm11071880] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
70 Alimoradi N, Sharqi M, Firouzabadi D, Sadeghi MM, Moezzi MI, Firouzabadi N. SNPs of ACE1 (rs4343) and ACE2 (rs2285666) genes are linked to SARS-CoV-2 infection but not with the severity of disease. Virol J 2022;19. [DOI: 10.1186/s12985-022-01782-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
71 Nie XB, Shi BS, Zhang L, Niu WL, Xue T, Li LQ, Wei XY, Wang YD, Chen WD, Hou RF. Epidemiological features and dynamic changes in blood biochemical indices for COVID-19 patients in Hebi. World J Clin Cases 2022; 10(8): 2404-2419 [DOI: 10.12998/wjcc.v10.i8.2404] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Chamtouri I, Kaddoussi R, Abroug H, Hafsa M, Abdeleli M, Fahem N, Lassoued T, Abdallah AB, Achour A, Migaou A, Cheikhm’hamed S, Jomaa W, Sriha A, Hamda KB, Maatouk F. Mid-term subclinical myocardial injury detection in patients recovered from COVID-19 according pulmonary lesion severity.. [DOI: 10.1101/2022.03.14.22272130] [Reference Citation Analysis]
73 Yildirim Y, Yurdalan U. Which Body Systems Will Require Rehabilitation After Recovery From Covid-19?: Descriptive Review. CBU-SBED 2022. [DOI: 10.34087/cbusbed.994558] [Reference Citation Analysis]
74 Al-Tamimi AO, Yusuf AM, Jayakumar MN, Ansari AW, Elhassan M, AbdulKarim F, Kannan M, Halwani R, Ahmad F. SARS-CoV-2 infection induces soluble platelet activation markers and PAI-1 in the early moderate stage of COVID-19. Int J Lab Hematol 2022. [PMID: 35266284 DOI: 10.1111/ijlh.13829] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
75 Singha M, Madathanapalli A, Parikh R. COVID-19 and Cardiac Enzymes. Cardiac Arrhythmias - Translational Approach from Pathophysiology to Advanced Care 2022. [DOI: 10.5772/intechopen.101402] [Reference Citation Analysis]
76 Palmos AB, Millischer V, Menon DK, Nicholson TR, Taams LS, Michael B, Sunderland G, Griffiths MJ, Hübel C, Breen G; COVID Clinical Neuroscience Study Consortium. Proteome-wide Mendelian randomization identifies causal links between blood proteins and severe COVID-19. PLoS Genet 2022;18:e1010042. [PMID: 35239653 DOI: 10.1371/journal.pgen.1010042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
77 Xie LM, Huang YF, Liu YL, Liang JQ, Deng W, Lin GL, Luo HM, Guo XG. Identification of the Hub Genes and the Signaling Pathways in Human iPSC-Cardiomyocytes Infected by SARS-CoV-2. Biochem Genet 2022. [PMID: 35235083 DOI: 10.1007/s10528-022-10206-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Zemlin AE, Allwood B, Erasmus RT, Matsha TE, Chapanduka ZC, Jalavu TP, Ngah V, Sigwadhi LN, Koegelenberg CF, Irusen E, Lalla U, Yalew A, Baines N, Tamuzi JL, Barasa AK, Magutu VK, Njeru C, Amayo A, Mureithi MW, Mungania M, Sono-setati M, Zumla A, Nyasulu PS. Prognostic value of biochemical parameters among severe COVID-19 patients admitted to an intensive care unit of a tertiary hospital in South Africa. IJID Regions 2022;2:191-197. [DOI: 10.1016/j.ijregi.2022.01.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
79 Kite TA, Pallikadavath S, Gale CP, Curzen N, Ladwiniec A. The Direct and Indirect Effects of COVID-19 on Acute Coronary Syndromes. Cardiology Clinics 2022. [DOI: 10.1016/j.ccl.2022.03.002] [Reference Citation Analysis]
80 Montero S, Abrams D, Ammirati E, Huang F, Donker DW, Hekimian G, García-García C, Bayes-Genis A, Combes A, Schmidt M. Fulminant myocarditis in adults: a narrative review. J Geriatr Cardiol 2022;19:137-51. [PMID: 35317391 DOI: 10.11909/j.issn.1671-5411.2022.02.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
81 Rasmi Y, Mosa OF, Alipour S, Heidari N, Javanmard F, Golchin A, Gholizadeh-ghaleh Aziz S. Significance of Cardiac Troponins as an Identification Tool in COVID-19 Patients Using Biosensors: An Update. Front Mol Biosci 2022;9:821155. [DOI: 10.3389/fmolb.2022.821155] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Meyer AA, Mathews EH, Gous AGS, Mathews MJ. Using a Systems Approach to Explore the Mechanisms of Interaction Between Severe Covid-19 and Its Coronary Heart Disease Complications. Front Cardiovasc Med 2022;9:737592. [DOI: 10.3389/fcvm.2022.737592] [Reference Citation Analysis]
83 Bursi F, Santangelo G, Barbieri A, Vella AM, Toriello F, Valli F, Sansalone D, Carugo S, Guazzi M. Impact of Right Ventricular‐Pulmonary Circulation Coupling on Mortality in SARS‐CoV‐2 Infection. JAHA. [DOI: 10.1161/jaha.121.023220] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Khodavirdipour A, Chamanrokh P, Alikhani MY, Alikhani MS. Potential of Bacillus subtilis Against SARS-CoV-2 – A Sustainable Drug Development Perspective. Front Microbiol 2022;13:718786. [DOI: 10.3389/fmicb.2022.718786] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
85 Ismayl M, Abusnina W, Thandra A, Sabri A, Groh D, Kanmanthareddy A, Alla VM. Delayed acute myocarditis with COVID-19 infection. Baylor University Medical Center Proceedings. [DOI: 10.1080/08998280.2022.2030189] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
86 Rifaie O, Reda A, Hatata A, Gamal A, Abdelmonaem M. Short-term impact of COVID-19 infection on right ventricular functions: single center observational study. Egypt Heart J 2022;74:7. [PMID: 35107643 DOI: 10.1186/s43044-022-00242-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
87 Salabei JK, Asnake ZT, Ismail ZH, Charles K, Stanger G, Abdullahi AH, Abraham AT, Okonoboh P. COVID-19 and the Cardiovascular System: An Update. The American Journal of the Medical Sciences 2022. [DOI: 10.1016/j.amjms.2022.01.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
88 Mitrani R, Alfadhli J, Lowery M, Best T, Hare J, Fishman J, Dong C, Siegel Y, Scavo V, Basham G, Myerburg R, Goldberger J. Utility of exercise testing to assess athletes for post COVID-19 myocarditis. American Heart Journal Plus: Cardiology Research and Practice 2022;14:100125. [DOI: 10.1016/j.ahjo.2022.100125] [Reference Citation Analysis]
89 Sexson Tejtel SK, Munoz FM, Al-Ammouri I, Savorgnan F, Guggilla RK, Khuri-Bulos N, Phillips L, Engler RJM. Myocarditis and pericarditis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine 2022:S0264-410X(21)01548-6. [PMID: 35105494 DOI: 10.1016/j.vaccine.2021.11.074] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
90 INSPIRATION-S Investigators. Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial. BMJ 2022;376:e068407. [PMID: 34996756 DOI: 10.1136/bmj-2021-068407] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
91 Schoene D, Schnekenberg LG, Pallesen LP, Barlinn J, Puetz V, Barlinn K, Siepmann T. Pathophysiology of Cardiac Injury in COVID-19 Patients with Acute Ischaemic Stroke: What Do We Know So Far?-A Review of the Current Literature. Life (Basel) 2022;12:75. [PMID: 35054468 DOI: 10.3390/life12010075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Kuzeytemiz M, Tenekecioglu E. Effect of renin-angiotensin system blocker on COVID-19 in young patients with hypertension. J Investig Med 2022:jim-2021-002036. [PMID: 34987107 DOI: 10.1136/jim-2021-002036] [Reference Citation Analysis]
93 Rubakova AA, Lebedeva JI, Turovina EF, I SC, Khasanova LT, Suvorov AJ, Kazakova ZD. [Clinical and pathophysiological features of stroke in patients with COVID-19]. Zh Nevrol Psikhiatr Im S S Korsakova 2022;122:26-32. [PMID: 36582158 DOI: 10.17116/jnevro202212212226] [Reference Citation Analysis]
94 Özyildiz A, Ergül E, Emlek N, Özyildiz A, Duman H, Çetin M. Effect of coronavirus disease-2019 infection on left atrial functions. J Cardiovasc Echography 2022;32:89. [DOI: 10.4103/jcecho.jcecho_83_21] [Reference Citation Analysis]
95 Yu X, Xu X, Wu T, Huang W, Xu C, Xie W, Long X. APOA1 Level is Negatively Correlated with the Severity of COVID-19. IJGM 2022;Volume 15:689-98. [DOI: 10.2147/ijgm.s332956] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
96 Rogers RG, Marbán E. Novel Cell-Based Therapeutics for Diseases of the Heart and Skeletal Muscle. Physiology in Health and Disease 2022. [DOI: 10.1007/978-3-030-95884-8_7] [Reference Citation Analysis]
97 Sadeghi HA. The Heart and Pulmonary Diseases. Practical Cardiology 2022. [DOI: 10.1016/b978-0-323-80915-3.00038-7] [Reference Citation Analysis]
98 Wade H, Duan Q, Su Q. Interaction between Sars-CoV-2 structural proteins and host cellular receptors: From basic mechanisms to clinical perspectives. Adv Protein Chem Struct Biol 2022;132:243-77. [PMID: 36088078 DOI: 10.1016/bs.apcsb.2022.05.010] [Reference Citation Analysis]
99 Metzler B, Lechner I, Reindl M, Reinstadler SJ. Cardiac injury after COVID-19: Primary cardiac and primary non-cardiac etiology makes a difference. Int J Cardiol 2022:S0167-5273(21)02058-1. [PMID: 34979150 DOI: 10.1016/j.ijcard.2021.12.055] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
100 Gámez JM, Aguilera A, Barrios V, Cosín-sales J, Freixa-pamias R, Marzoa R, Rincón LM, Vivas D. Selección de lo mejor del año 2021 en cardiología clínica y COVID-19. REC: CardioClinics 2022;57:S17-S22. [DOI: 10.1016/j.rccl.2021.10.008] [Reference Citation Analysis]
101 Blanch-Ruiz MA, Ortega-Luna R, Gómez-García G, Martínez-Cuesta MÁ, Álvarez Á. Role of Neutrophil Extracellular Traps in COVID-19 Progression: An Insight for Effective Treatment. Biomedicines 2021;10:31. [PMID: 35052711 DOI: 10.3390/biomedicines10010031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
102 Charfeddine S, Ibn Hadj Amor H, Jdidi J, Torjmen S, Kraiem S, Hammami R, Bahloul A, Kallel N, Moussa N, Touil I, Ghrab A, Elghoul J, Meddeb Z, Thabet Y, Kammoun S, Bouslama K, Milouchi S, Abdessalem S, Abid L. Long COVID 19 Syndrome: Is It Related to Microcirculation and Endothelial Dysfunction? Insights From TUN-EndCOV Study. Front Cardiovasc Med 2021;8:745758. [PMID: 34917659 DOI: 10.3389/fcvm.2021.745758] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 16.0] [Reference Citation Analysis]
103 Izquierdo A, Mojón D, Bardají A, Carrasquer A, Calvo-Fernández A, Carreras-Mora J, Giralt T, Pérez-Fernández S, Farré N, Soler C, Solà-Richarte C, Cabero P, Vaquerizo B, Marrugat J, Ribas N. Myocardial Injury as a Prognostic Factor in Mid- and Long-Term Follow-Up of COVID-19 Survivors. J Clin Med 2021;10:5900. [PMID: 34945196 DOI: 10.3390/jcm10245900] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
104 Henein MY, Mandoli GE, Pastore MC, Ghionzoli N, Hasson F, Nisar MK, Islam M, Bandera F, Marrocco-Trischitta MM, Baroni I, Malagoli A, Rossi L, Biagi A, Citro R, Ciccarelli M, Silverio A, Biagioni G, Moutiris JA, Vancheri F, Mazzola G, Geraci G, Thomas L, Altman M, Pernow J, Ahmed M, Santoro C, Esposito R, Casas G, Fernández-Galera R, Gonzalez M, Rodriguez Palomares J, Bytyçi I, Dini FL, Cameli P, Franchi F, Bajraktari G, Badano LP, Cameli M. Biomarkers Predict In-Hospital Major Adverse Cardiac Events in COVID-19 Patients: A Multicenter International Study. J Clin Med 2021;10. [PMID: 34945166 DOI: 10.3390/jcm10245863] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
105 Weng H, Yang F, Zhang L, Jin H, Liu S, Fan F, Liu Z, Zheng X, Yang H, Li Y, Yi T, Li H, Zhang Y, Li J. Joint Predictive Value of cTnI and NT-proBNP on Mortality in Patients with Coronavirus Disease 2019: A Retrospective Research in Wuhan, China. J Transl Int Med 2021;9:177-84. [PMID: 34900628 DOI: 10.2478/jtim-2021-0034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
106 Teoh SE, Masuda Y, Tan DJH, Liu N, Morrison LJ, Ong MEH, Blewer AL, Ho AFW. Impact of the COVID-19 pandemic on the epidemiology of out-of-hospital cardiac arrest: a systematic review and meta-analysis. Ann Intensive Care 2021;11:169. [PMID: 34874498 DOI: 10.1186/s13613-021-00957-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
107 Ertekin B, Yortanlı M, Özelbaykal O, Doğru A, Girişgin AS, Acar T. The Relationship between Routine Blood Parameters and the Prognosis of COVID-19 Patients in the Emergency Department. Emerg Med Int 2021;2021:7489675. [PMID: 34868686 DOI: 10.1155/2021/7489675] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
108 Ciochetto Z, Havens PL, Aldrete S. Two cases of multi-inflammatory syndrome in children (MIS-C) in adults in 2020. BMC Infect Dis 2021;21:1228. [PMID: 34876052 DOI: 10.1186/s12879-021-06911-0] [Reference Citation Analysis]
109 Doroshenko DA, Rumyantsev YI, Konisheva OV, Samorukova AS, Vechorko VI, Adamyan LV. Left Ventricular Global Longitudinal Strain by Speckle Tracking Echocardiography in Pregnant COVID-19 Patients. Annals RAMS 2021;76:539-543. [DOI: 10.15690/vramn1610] [Reference Citation Analysis]
110 Sirvent JM, Baro A, Morales M, Sebastian P, Saiz X. Predictive biomarkers of mortality in critically ill patients with COVID-19. Med Intensiva (Engl Ed) 2021:S2173-5727(21)00169-7. [PMID: 34863670 DOI: 10.1016/j.medine.2021.11.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
111 Jeyalan V, Storrar J, Wu HHL, Ponnusamy A, Sinha S, Kalra PA, Chinnadurai R. Native and transplant kidney histopathological manifestations in association with COVID-19 infection: A systematic review. World J Transplant 2021; 11(11): 480-502 [PMID: 34868898 DOI: 10.5500/wjt.v11.i11.480] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
112 Šikić J, Planinić Z, Matišić V, Friščić T, Molnar V, Jagačić D, Vujičić L, Tudorić N, Postružin Gršić L, Ljubičić Đ, Primorac D. COVID-19: The Impact on Cardiovascular System. Biomedicines 2021;9:1691. [PMID: 34829920 DOI: 10.3390/biomedicines9111691] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
113 Larijani B, Foroughi-Heravani N, Abedi M, Tayanloo-Beik A, Rezaei-Tavirani M, Adibi H, Arjmand B. Recent Advances of COVID-19 Modeling Based on Regenerative Medicine. Front Cell Dev Biol 2021;9:683619. [PMID: 34760882 DOI: 10.3389/fcell.2021.683619] [Reference Citation Analysis]
114 Mustroph J, Hupf J, Baier MJ, Evert K, Brochhausen C, Broeker K, Meindl C, Seither B, Jungbauer C, Evert M, Maier LS, Wagner S. Cardiac Fibrosis Is a Risk Factor for Severe COVID-19. Front Immunol 2021;12:740260. [PMID: 34745111 DOI: 10.3389/fimmu.2021.740260] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
115 Pelà G, Goldoni M, Cavalli C, Perrino F, Tagliaferri S, Frizzelli A, Mori PA, Majori M, Aiello M, Sverzellati N, Corradi M, Chetta A. Long-Term Cardiac Sequelae in Patients Referred into a Diagnostic Post-COVID-19 Pathway: The Different Impacts on the Right and Left Ventricles. Diagnostics (Basel) 2021;11:2059. [PMID: 34829406 DOI: 10.3390/diagnostics11112059] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
116 Alvarez Villela MA, Alkhalil A, Weinreich MA, Koslowsky J, Aoi S, Latib MA. Atypical ST-Segment-Elevation Myocardial Infarction Presentation in Patients With COVID-19 at a High-Volume Center in New York City. Tex Heart Inst J 2021;48:e207446. [PMID: 34913970 DOI: 10.14503/THIJ-20-7446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
117 García-Lamberechts EJ, Miró Ò, Fragiel M, Llorens P, Jiménez S, Piñera P, Burillo-Putze G, Martín A, Martín-Sánchez FJ, Jacob J, Alquézar-Arbé A, Ejarque Martínez L, Rodríguez Miranda B, Ruiz Grinspan M, Domínguez MJ, Teigell Muñoz FJ, Gayoso Martín S, García García Á, Iglesias Vela M, Carbajosa V, Salido Mota M, Marchena González MJ, Agüera Urbano C, Porta-Etessam J, Calvo E, González Del Castillo J; Spanish Investigators on Emergency Situations TeAm (SIESTA) network. A case-control analysis of stroke in COVID-19 patients: Results of unusual manifestations of COVID-19-study 11. Acad Emerg Med 2021;28:1236-50. [PMID: 34490961 DOI: 10.1111/acem.14389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
118 Idalsoaga F, Ayares G, Arab JP, Díaz LA. COVID-19 and Indirect Liver Injury: A Narrative Synthesis of the Evidence. J Clin Transl Hepatol 2021;9:760-8. [PMID: 34722191 DOI: 10.14218/JCTH.2020.00140] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
119 Ahmad F, Kannan M, Ansari AW. Role of SARS-CoV-2 -induced cytokines and growth factors in coagulopathy and thromboembolism. Cytokine Growth Factor Rev 2021:S1359-6101(21)00079-4. [PMID: 34750061 DOI: 10.1016/j.cytogfr.2021.10.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
120 Ventura D, Carr AL, Davis RD, Silvestry S, Bogar L, Raval N, Gries C, Hayes JE, Oliveira E, Sniffen J, Allison SL, Herrera V, Jennings DL, Page RL 2nd, McDyer JF, Ensor CR. Renin Angiotensin Aldosterone System Antagonism in 2019 Novel Coronavirus Acute Lung Injury. Open Forum Infect Dis 2021;8:ofab170. [PMID: 34642634 DOI: 10.1093/ofid/ofab170] [Reference Citation Analysis]
121 Angeli F, Reboldi G, Spanevello A, De Ponti R, Visca D, Marazzato J, Zappa M, Trapasso M, Masnaghetti S, Fabbri LM, Verdecchia P. Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations. Eur J Intern Med 2021:S0953-6205(21)00336-8. [PMID: 34670682 DOI: 10.1016/j.ejim.2021.10.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
122 Colbenson K, Asplund CA, Raukar N. Adaptations to Protect Sideline Providers as They Respond to Sudden Cardiac Arrest During Sars-CoV-2. Curr Sports Med Rep 2021;20:540-4. [PMID: 34622819 DOI: 10.1249/JSR.0000000000000892] [Reference Citation Analysis]
123 Kyriakoulis KG, Kollias A, Poulakou G, Kyriakoulis IG, Trontzas IP, Charpidou A, Syrigos K. The Effect of Anakinra in Hospitalized Patients with COVID-19: An Updated Systematic Review and Meta-Analysis. J Clin Med 2021;10:4462. [PMID: 34640480 DOI: 10.3390/jcm10194462] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
124 Martens CR, Accornero F. Viruses in the Heart: Direct and Indirect Routes to Myocarditis and Heart Failure. Viruses 2021;13:1924. [PMID: 34696354 DOI: 10.3390/v13101924] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
125 Majeed M, Noor T. The Extrapulmonary Manifestations of SARS-CoV-2. TOCOVIDJ 2021;1:80-92. [DOI: 10.2174/2666958702101010080] [Reference Citation Analysis]
126 Amin MS, Wozniak M, Barbaric L, Pickard S, Yerrabelli RS, Christensen A, Coiado OC. Experimental Technologies in the Diagnosis and Treatment of COVID-19 in Patients with Comorbidities. J Healthc Inform Res 2021;:1-24. [PMID: 34541448 DOI: 10.1007/s41666-021-00106-7] [Reference Citation Analysis]
127 Liu D, Zeng X, Ding Z, Lv F, Mehta JL, Wang X. Adverse Cardiovascular Effects of Anti-COVID-19 Drugs. Front Pharmacol 2021;12:699949. [PMID: 34512335 DOI: 10.3389/fphar.2021.699949] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
128 Rasmi Y, Babaei G, Nisar MF, Noreen H, Gholizadeh-Ghaleh Aziz S. Revealed pathophysiological mechanisms of crosslinking interaction of affected vital organs in COVID-19. Comp Clin Path 2021;:1-17. [PMID: 34539310 DOI: 10.1007/s00580-021-03269-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
129 Fisun AY, Lobzin YV, Cherkashin DV, Tyrenko VV, Tkachenko KN, Kachnov VA, Kutelev GG, Rudchenko IV, Sobolev AD. Mechanisms of Damage to the Cardiovascular System in COVID-19. Annals RAMS 2021;76:287-297. [DOI: 10.15690/vramn1474] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
130 di Candia AM, de Avila DX, Moreira GR, Villacorta H, Maisel AS. Growth differentiation factor-15, a novel systemic biomarker of oxidative stress, inflammation, and cellular aging: Potential role in cardiovascular diseases. American Heart Journal Plus: Cardiology Research and Practice 2021;9:100046. [DOI: 10.1016/j.ahjo.2021.100046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
131 Kang YW, Lee SC, Jeon SM, Jo E. Roles of Interleukin-17 and Th17 Responses in COVID-19. jbv 2021;51:89-102. [DOI: 10.4167/jbv.2021.51.3.089] [Reference Citation Analysis]
132 Frisoni P, Neri M, D'Errico S, Alfieri L, Bonuccelli D, Cingolani M, Di Paolo M, Gaudio RM, Lestani M, Marti M, Martelloni M, Moreschi C, Santurro A, Scopetti M, Turriziani O, Zanon M, Scendoni R, Frati P, Fineschi V. Cytokine storm and histopathological findings in 60 cases of COVID-19-related death: from viral load research to immunohistochemical quantification of major players IL-1β, IL-6, IL-15 and TNF-α. Forensic Sci Med Pathol 2021. [PMID: 34463916 DOI: 10.1007/s12024-021-00414-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
133 Hossain MI, Shahriar EB, Sarker A, Lubna N, Haque M, Khalil MI. Effects of COVID-19 on vital organs in patients infected with SARS-CoV-2. GHM Open 2021;1:12-19. [DOI: 10.35772/ghmo.2021.01010] [Reference Citation Analysis]
134 Law CC, Puranik R, Fan J, Fei J, Hambly BD, Bao S. Clinical Implications of IL-32, IL-34 and IL-37 in Atherosclerosis: Speculative Role in Cardiovascular Manifestations of COVID-19. Front Cardiovasc Med 2021;8:630767. [PMID: 34422917 DOI: 10.3389/fcvm.2021.630767] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
135 Al-tamimi AO, Yusuf AM, Jayakumar MN, Ansari AW, Elhassan M, Abdulkarim F, Kannan M, Halwani R, Ahmad F. SARS-CoV-2 infection induces soluble platelet activation markers and PAI-1 in the early moderate stage of COVID-19.. [DOI: 10.1101/2021.08.23.457378] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
136 Laher N, Bocchinfuso S, Chidiac M, Doherty C, Persson A, Warren E. The Biopsychosocial Impact of COVID-19 on Older Adults. Gerontol Geriatr Med 2021;7:23337214211034274. [PMID: 34414252 DOI: 10.1177/23337214211034274] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
137 Tao J, Aristotelidis R, Zanowick-Marr A, Chambers LC, McDonald J, Mylonakis EE, Chan PA. Evaluation of the Treatment Efficacy and Safety of Remdesivir for COVID-19: a Meta-analysis. SN Compr Clin Med 2021;:1-12. [PMID: 34396045 DOI: 10.1007/s42399-021-01014-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
138 Wang BJ, Vadakke-madathil S, Croft LB, Brody RI, Chaudhry HW. HIF1alpha Cardioprotection in COVID-19 Patients.. [DOI: 10.1101/2021.08.05.21258160] [Reference Citation Analysis]
139 Colombo C, Garatti L, Ferrante G, Casadei F, Montalto C, Crimi G, Cogliati C, Ammirati E, Savonitto S, Morici N. Cardiovascular injuries and SARS-COV-2 infection: focus on elderly people. J Geriatr Cardiol 2021;18:534-48. [PMID: 34404990 DOI: 10.11909/j.issn.1671-5411.2021.07.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
140 Shuroog J, Raffetto J, Soherwardi S, Hassan M, Eng S, Nayim F. A Unique Case of Acute Coronary Syndrome in a Patient With COVID-19 Infection. Cureus 2021;13:e15650. [PMID: 34306860 DOI: 10.7759/cureus.15650] [Reference Citation Analysis]
141 Silalahi TDA, Suwita CS. Culture-negative pleural empyema after Coronavirus disease-19 resolution - A case report. Respir Med Case Rep 2021;34:101473. [PMID: 34307016 DOI: 10.1016/j.rmcr.2021.101473] [Reference Citation Analysis]
142 Isackson H, Larsson A, Lipcsey M, Frithiof R, Flachskampf FA, Hultström M. Echocardiographic characterisation in critical Covid19 - an observational study.. [DOI: 10.1101/2021.07.23.21261025] [Reference Citation Analysis]
143 Kotsev SV, Miteva D, Krayselska S, Shopova M, Pishmisheva-Peleva M, Stanilova SA, Velikova T. Hypotheses and facts for genetic factors related to severe COVID-19. World J Virol 2021; 10(4): 137-155 [PMID: 34367930 DOI: 10.5501/wjv.v10.i4.137] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
144 Xiao K, Yang H, Liu B, Pang X, Du J, Liu M, Liu Y, Jing X, Chen J, Deng S, Zhou Z, Du J, Yin L, Yan Y, Mou H, She Q. Antibodies Can Last for More Than 1 Year After SARS-CoV-2 Infection: A Follow-Up Study From Survivors of COVID-19. Front Med (Lausanne) 2021;8:684864. [PMID: 34336891 DOI: 10.3389/fmed.2021.684864] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
145 Kinaneh S, Khamaysi I, Karram T, Hamoud S. Heparanase as a potential player in SARS-CoV-2 infection and induced coagulopathy. Biosci Rep 2021;41:BSR20210290. [PMID: 34132790 DOI: 10.1042/BSR20210290] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
146 Akkaya F, Yenerçağ FNT, Kaya A, Şener YZ, Bağcı A. Long term effects of mild severity COVID‑19 on right ventricular functions. Int J Cardiovasc Imaging 2021. [PMID: 34251551 DOI: 10.1007/s10554-021-02340-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
147 Zanza C, Tassi MF, Romenskaya T, Piccolella F, Abenavoli L, Franceschi F, Piccioni A, Ojetti V, Saviano A, Canonico B, Montanari M, Zamai L, Artico M, Robba C, Racca F, Longhitano Y. Lock, Stock and Barrel: Role of Renin-Angiotensin-Aldosterone System in Coronavirus Disease 2019. Cells 2021;10:1752. [PMID: 34359922 DOI: 10.3390/cells10071752] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
148 Pařízek P. Cardiovascular complications and covid-19 infection. Intervencni a akutni kardiologie 2021;20:78-80. [DOI: 10.36290/kar.2021.024] [Reference Citation Analysis]
149 He J, Zhang B, Zhou Q, Yang W, Xu J, Liu T, Zhang H, Wu Z, Li D, Zhou Q, Yan J, Zhang C, Qian H, Lu M, Zhou X. The prognostic value of myocardial injury in COVID-19 patients and associated characteristics. Immun Inflamm Dis 2021. [PMID: 34240818 DOI: 10.1002/iid3.484] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
150 Shi C, Wang L, Ye J, Gu Z, Wang S, Xia J, Xie Y, Li Q, Xu R, Lin N. Predictors of mortality in patients with coronavirus disease 2019: a systematic review and meta-analysis. BMC Infect Dis 2021;21:663. [PMID: 34238232 DOI: 10.1186/s12879-021-06369-0] [Cited by in Crossref: 52] [Cited by in F6Publishing: 60] [Article Influence: 26.0] [Reference Citation Analysis]
151 Kuzeytemiz M. Does Hypertension Alone Increase Mortality In Young Hypertensive Patients With COVİD-19? Single Center Retrospective Study Of 100 Patients. Ahi Evran Medical Journal 2021. [DOI: 10.46332/aemj.845972] [Reference Citation Analysis]
152 Trilling M. What the HEC happens around the heart during COVID-19? Basic Res Cardiol 2021;116:43. [PMID: 34223971 DOI: 10.1007/s00395-021-00883-7] [Reference Citation Analysis]
153 Ahmad Z, Goswami S, Paneerselvam A, Kabilan K, Chowdhury H, Roy A, Guleria R, Soni KD, Baruah U, Das CJ. Imaging of Coronavirus Disease 2019 Infection From Head to Toe: A Primer for the Radiologist. Curr Probl Diagn Radiol 2021:S0363-0188(21)00113-4. [PMID: 34330569 DOI: 10.1067/j.cpradiol.2021.06.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
154 Firdaus Z, Singh SK, Singh TD, Singh M. The scientific community in COVID-19 global pandemic: A systematic update on recent progress and challenges. Eur J Chem 2021;12:222-234. [DOI: 10.5155/eurjchem.12.2.222-234.2084] [Reference Citation Analysis]
155 Magomedov A, Zickler D, Karaivanov S, Kurreck A, Münch FH, Kamhieh-Milz J, Ferse C, Kahl A, Piper SK, Eckardt KU, Dörner T, Kruse JM. Viscoelastic testing reveals normalization of the coagulation profile 12 weeks after severe COVID-19. Sci Rep 2021;11:13325. [PMID: 34172793 DOI: 10.1038/s41598-021-92683-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
156 Negron SG, Kessinger CW, Xu B, Pu WT, Lin Z. Selectively expressing SARS-CoV-2 Spike protein S1 subunit in cardiomyocytes induces cardiac hypertrophy in mice.. [DOI: 10.1101/2021.06.20.448993] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
157 Mester A, Benedek I, Rat N, Tolescu C, Polexa SA, Benedek T. Imaging Cardiovascular Inflammation in the COVID-19 Era. Diagnostics (Basel) 2021;11:1114. [PMID: 34207266 DOI: 10.3390/diagnostics11061114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
158 Ceylan H. A bioinformatics approach for identifying potential molecular mechanisms and key genes involved in COVID-19 associated cardiac remodeling. Gene Rep 2021;24:101246. [PMID: 34131597 DOI: 10.1016/j.genrep.2021.101246] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
159 Ayola-Serrano NC, Roy N, Fathah Z, Anwar MM, Singh B, Ammar N, Sah R, Elba A, Utt RS, Pecho-Silva S, Rodriguez-Morales AJ, Dhama K, Quraishi S. The role of 5-lipoxygenase in the pathophysiology of COVID-19 and its therapeutic implications. Inflamm Res 2021;70:877-89. [PMID: 34086061 DOI: 10.1007/s00011-021-01473-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
160 Sang L, Guo X, Shi J, Hou S, Fan H, Lv Q. Characteristics and Developments in Mesenchymal Stem Cell Therapy for COVID-19: An Update. Stem Cells Int 2021;2021:5593584. [PMID: 34211556 DOI: 10.1155/2021/5593584] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
161 Al-Baadani A, Eltayeb N, Alsufyani E, Albahrani S, Basheri S, Albayat H, Batubara E, Ballool S, Al Assiri A, Faqihi F, Musa AB, Robert AA, Alsherbeeni N, Elzein F. Efficacy of tocilizumab in patients with severe COVID-19: Survival and clinical outcomes. J Infect Public Health 2021;14:1021-7. [PMID: 34153727 DOI: 10.1016/j.jiph.2021.05.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
162 Pan Y, Yu Z, Yuan Y, Han J, Wang Z, Chen H, Wang S, Wang Z, Hu H, Zhou L, Lai Y, Zhou Z, Wang Y, Meng G, Yu L, Jiang H. Alteration of Autonomic Nervous System Is Associated With Severity and Outcomes in Patients With COVID-19. Front Physiol 2021;12:630038. [PMID: 34093217 DOI: 10.3389/fphys.2021.630038] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
163 Yassin A, Ghzawi A, Al-Mistarehi AH, El-Salem K, Y Benmelouka A, M Sherif A, BenhadjDahman N, AlAdamat N, Jemel A, Negida A, Abdelmonem M. Mortality rate and biomarker expression within COVID-19 patients who develop acute ischemic stroke: a systematic review and meta-analysis. Future Sci OA 2021;7:FSO713. [PMID: 34254031 DOI: 10.2144/fsoa-2021-0036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
164 Brannagan TH 3rd, Auer-Grumbach M, Berk JL, Briani C, Bril V, Coelho T, Damy T, Dispenzieri A, Drachman BM, Fine N, Gaggin HK, Gertz M, Gillmore JD, Gonzalez E, Hanna M, Hurwitz DR, Khella SL, Maurer MS, Nativi-Nicolau J, Olugemo K, Quintana LF, Rosen AM, Schmidt HH, Shehata J, Waddington-Cruz M, Whelan C, Ruberg FL. ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable. Orphanet J Rare Dis 2021;16:204. [PMID: 33957949 DOI: 10.1186/s13023-021-01834-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
165 Tolunay H, Tolunay T. Role of striated muscles in the pathogenesis of COVID-19. Cardiovasc Revasc Med 2021:S1553-8389(21)00247-5. [PMID: 33965336 DOI: 10.1016/j.carrev.2021.05.003] [Reference Citation Analysis]
166 Antunez Muiños PJ, López Otero D, Amat-Santos IJ, López País J, Aparisi A, Cacho Antonio CE, Catalá P, González Ferrero T, Cabezón G, Otero García O, Gil JF, Pérez Poza M, Candela J, Rojas G, Jiménez Ramos V, Veras C, San Román JA, González-Juanatey JR. The COVID-19 lab score: an accurate dynamic tool to predict in-hospital outcomes in COVID-19 patients. Sci Rep 2021;11:9361. [PMID: 33931677 DOI: 10.1038/s41598-021-88679-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
167 Ruksakulpiwat S. The impact of COVID-19 on patients with stroke: an integrative review. JHR 2021. [DOI: 10.1108/jhr-12-2020-0615] [Reference Citation Analysis]
168 Beura SK, Panigrahi AR, Yadav P, Singh SK. Phytochemicals as Potential Therapeutics for SARS-CoV-2-Induced Cardiovascular Complications: Thrombosis and Platelet Perspective. Front Pharmacol 2021;12:658273. [PMID: 33981235 DOI: 10.3389/fphar.2021.658273] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
169 Lozahic C, Maddock H, Sandhu H. Anti-cancer Therapy Leads to Increased Cardiovascular Susceptibility to COVID-19. Front Cardiovasc Med 2021;8:634291. [PMID: 33969006 DOI: 10.3389/fcvm.2021.634291] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
170 Shi MJ, Lv JG, Lin L, Guo JY. Trends in Coronavirus Disease 2019 Hospitalization and Prognosis: Gender Effect. Curr Med Sci 2021;41:312-7. [PMID: 33877547 DOI: 10.1007/s11596-021-2348-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
171 Nurlu Temel E. COVID-19 Tedavisinde Kolşisin ve Non-steroid Anti-inflamatuar İlaç Uygulamaları. SDÜ Tıp Fakültesi Dergisi 2021. [DOI: 10.17343/sdutfd.905173] [Reference Citation Analysis]
172 Yaroshchuk NА, Kochmasheva VV, Vakhrameev AV. Cardiac complications in patients with severe COVID-19 pneumonia. Medicinskij alfavit 2021. [DOI: 10.33667/2078-5631-2021-5-14-17] [Reference Citation Analysis]
173 Naz A, Billah M. COVID-19 and Coronary Heart Disease. Encyclopedia 2021;1:340-9. [DOI: 10.3390/encyclopedia1020028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
174 Keskin M. ÇOCUKLARDA COVİD-19 ENFEKSİYONUNDA KALP TUTULUMU,. SDÜ Tıp Fakültesi Dergisi 2021. [DOI: 10.17343/sdutfd.905829] [Reference Citation Analysis]
175 Savoia C, Volpe M, Kreutz R. Hypertension, a Moving Target in COVID-19: Current Views and Perspectives. Circ Res 2021;128:1062-79. [PMID: 33793331 DOI: 10.1161/CIRCRESAHA.121.318054] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 14.5] [Reference Citation Analysis]
176 Naseri E, Mohammadghasemi F, Shams F, Saliminasab S, Karimian P, Rahbar Taramsari M, Kordrostami S, Alavi Foumani A, Hemmati H, Hojati SA, Samidoust P, Faghani M, Student Research Committee, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran, Cellular and Molecular Research Center, Guilan University of Medical Sciences, Rasht, Iran, Student Research Committee, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran, Student Research Committee, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran, Dept. of Pathology, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran, Dept. of Forensic Medicine, School of Medicine, Guilan University of Medical Sciences. Rasht, Iran, Razi Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran, Inflammatory Lung Diseases Research Center, Dept. of Internal Medicine, Razi Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran, Dept. of General Surgery, Division of Vascular Surgery, Guilan University of Medical Sciences, Rasht, Iran, Gastrointestinal and Liver Diseases Research Center (GLDRC), Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran, Dept .of General Surgery, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran, Cellular and Molecular Research Center, Guilan University of Medical Sciences, Rasht, Iran. Histopathological and Serological Findings of Lung, Liver and Heart in a Patient with Corona Virus Disease-2019 (COVID -19): A Case Report. J Adv Med Biomed Res 2021;29:183-188. [DOI: 10.30699/jambs.29.134.183] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
177 Vukomanovic V, Krasic S, Minic P, Petrovic G, Nesic D, Paripovic A, Vasiljevic M, Gobeljic B. Kawasaki-like disease and acute myocarditis in the SARS-CoV-2 pandemic - reports of three adolescents. Bosn J Basic Med Sci 2021;21:252. [PMID: 33119481 DOI: 10.17305/bjbms.2020.5037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
178 Parsons S, Tran VL. The Trilogy of SARS-CoV-2 in Pediatrics (Part 1): Acute COVID-19 in Special Populations. J Pediatr Pharmacol Ther 2021;26:220-39. [PMID: 33833623 DOI: 10.5863/1551-6776-26.3.220] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
179 Yassin A, Nawaiseh M, Shaban A, Alsherbini K, El-Salem K, Soudah O, Abu-Rub M. Neurological manifestations and complications of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. BMC Neurol 2021;21:138. [PMID: 33784985 DOI: 10.1186/s12883-021-02161-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 14.0] [Reference Citation Analysis]
180 Pérez-Acosta G, Santana-Cabrera L, Blanco-López J, Martín-González JC. COVID-19 myopericarditis: A case report. Rev Clin Esp (Barc) 2021;221:312-3. [PMID: 33998522 DOI: 10.1016/j.rceng.2020.11.004] [Reference Citation Analysis]
181 Canalella A, Vitale E, Vella F, Senia P, Cannizzaro E, Ledda C, Rapisarda V. How the Heart Was Involved in COVID-19 during the First Pandemic Phase: A Review. Epidemiologia (Basel) 2021;2:124-39. [PMID: 36417195 DOI: 10.3390/epidemiologia2010011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
182 Shah KS, Hale Hammond ME, Drakos SG, Anderson JL, Fang JC, Knowlton KU, Shaw RM. SARS-CoV-2 as an inflammatory cardiovascular disease: current knowledge and future challenges. Future Cardiol 2021. [PMID: 33739142 DOI: 10.2217/fca-2020-0188] [Reference Citation Analysis]
183 Armaly Z, Kinaneh S, Skorecki K. Renal Manifestations of Covid-19: Physiology and Pathophysiology. J Clin Med 2021;10:1216. [PMID: 33804075 DOI: 10.3390/jcm10061216] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
184 Ajaz S, Sai Satish O, Rashid A. Clinical, Angiographic Profile and Immediate Outcome of COVID-19 Patients Presenting as Acute Coronary Syndrome: An Observational Study. Trends in Medical Research 2021;16:55-61. [DOI: 10.3923/tmr.2021.55.61] [Reference Citation Analysis]
185 Verhoef PA, Kannan S, Sturgill JL, Tucker EW, Morris PE, Miller AC, Sexton TR, Koyner JL, Hejal R, Brakenridge SC, Moldawer LL, Hotchkiss RS, Blood TM, Mazer MB, Bolesta S, Alexander SA, Armaignac DL, Shein SL, Jones C, Hoemann CD, Doctor A, Friess SH, Parker RI, Rotta AT, Remy KE. Severe Acute Respiratory Syndrome-Associated Coronavirus 2 Infection and Organ Dysfunction in the ICU: Opportunities for Translational Research. Crit Care Explor 2021;3:e0374. [PMID: 33786450 DOI: 10.1097/CCE.0000000000000374] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
186 Palmos AB, Millischer V, Menon DK, Nicholson TR, Taams L, Michael B, Hübel C, Breen G, COVID Clinical Neuroscience Study Consortium. Proteome-wide Mendelian randomization identifies causal links between blood proteins and severe COVID-19.. [DOI: 10.1101/2021.03.09.21253206] [Reference Citation Analysis]
187 Dariolli R, Campana C, Gutierrez A, Sobie EA. In vitro and In silico Models to Study SARS-CoV-2 Infection: Integrating Experimental and Computational Tools to Mimic "COVID-19 Cardiomyocyte". Front Physiol 2021;12:624185. [PMID: 33679437 DOI: 10.3389/fphys.2021.624185] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
188 Lonare S, Hazarika M, Das CK. Antiviral effect of amiodarone and its possible role in COVID-19: An appraisal. Indian J Pharmacol 2020;52:533-4. [PMID: 33666199 DOI: 10.4103/ijp.IJP_714_20] [Reference Citation Analysis]
189 Park YJ, Farooq J, Cho J, Sadanandan N, Cozene B, Gonzales-Portillo B, Saft M, Borlongan MC, Borlongan MC, Shytle RD, Willing AE, Garbuzova-Davis S, Sanberg PR, Borlongan CV. Fighting the War Against COVID-19 via Cell-Based Regenerative Medicine: Lessons Learned from 1918 Spanish Flu and Other Previous Pandemics. Stem Cell Rev Rep 2021;17:9-32. [PMID: 32789802 DOI: 10.1007/s12015-020-10026-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
190 Matteucci A, Massaro G, Sergi D, Bonanni M, Stifano G, Matino M, Zerillo B, Rogliani P, Romeo F. Electrocardiographic modifications and cardiac involvement in COVID-19 patients: results from an Italian cohort. J Cardiovasc Med (Hagerstown) 2021;22:190-6. [PMID: 33512975 DOI: 10.2459/JCM.0000000000001166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
191 Vitiello A, Ferrara F. Colchicine and SARS-CoV-2: Management of the hyperinflammatory state. Respir Med 2021;178:106322. [PMID: 33550151 DOI: 10.1016/j.rmed.2021.106322] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 18.0] [Reference Citation Analysis]
192 Benavides-córdoba V, Guerrero-jaramillo D, Betancourt-peña J. Pulmonary Rehabilitation in COVID-19: The Contribution of other Chronic Lung Syndromes for the Intervention of a Novel Disease. CRMR 2021;16:207-12. [DOI: 10.2174/1573398x17666210129124433] [Reference Citation Analysis]
193 Gasecka A, Pruc M, Kukula K, Gilis-Malinowska N, Filipiak KJ, Jaguszewski MJ, Szarpak L. Post-COVID-19 heart syndrome. Cardiol J 2021;28:353-4. [PMID: 33645626 DOI: 10.5603/CJ.a2021.0028] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
194 López-Cortés A, Guevara-Ramírez P, Kyriakidis NC, Barba-Ostria C, León Cáceres Á, Guerrero S, Ortiz-Prado E, Munteanu CR, Tejera E, Cevallos-Robalino D, Gómez-Jaramillo AM, Simbaña-Rivera K, Granizo-Martínez A, Pérez-M G, Moreno S, García-Cárdenas JM, Zambrano AK, Pérez-Castillo Y, Cabrera-Andrade A, Puig San Andrés L, Proaño-Castro C, Bautista J, Quevedo A, Varela N, Quiñones LA, Paz-Y-Miño C. In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19. Front Pharmacol 2021;12:598925. [PMID: 33716737 DOI: 10.3389/fphar.2021.598925] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
195 Fallahi I, Garimella M, Mitchell S, Burge MR. Effects of insulin detemir versus insulin glargine on food intake and satiety factors in type 1 diabetes. JDMDC 2021;8:31-36. [DOI: 10.15406/jdmdc.2021.08.00218] [Reference Citation Analysis]
196 Wang H, Li R, Zhou Z, Jiang H, Yan Z, Tao X, Li H, Xu L. Cardiac involvement in COVID-19 patients: mid-term follow up by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2021;23:14. [PMID: 33627143 DOI: 10.1186/s12968-021-00710-x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 19.0] [Reference Citation Analysis]
197 Liu J, Zhang L, Yan Y, Zhou Y, Yin P, Qi J, Wang L, Pan J, You J, Yang J, Zhao Z, Wang W, Liu Y, Lin L, Wu J, Li X, Chen Z, Zhou M. Excess mortality in Wuhan city and other parts of China during the three months of the covid-19 outbreak: findings from nationwide mortality registries. BMJ 2021;372:n415. [PMID: 33627311 DOI: 10.1136/bmj.n415] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 23.5] [Reference Citation Analysis]
198 Catapano F, Marchitelli L, Cundari G, Cilia F, Mancuso G, Pambianchi G, Galea N, Ricci P, Catalano C, Francone M. Role of advanced imaging in COVID-19 cardiovascular complications. Insights Imaging 2021;12:28. [PMID: 33625637 DOI: 10.1186/s13244-021-00973-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
199 Umbrajkar S, Stankowski RV, Rezkalla S, Kloner RA. Cardiovascular Health and Disease in the Context of COVID-19. Cardiol Res 2021;12:67-79. [PMID: 33738009 DOI: 10.14740/cr1199] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
200 Forte E, McLellan MA, Skelly DA, Rosenthal NA. Ex uno, plures-From One Tissue to Many Cells: A Review of Single-Cell Transcriptomics in Cardiovascular Biology. Int J Mol Sci 2021;22:2071. [PMID: 33669808 DOI: 10.3390/ijms22042071] [Reference Citation Analysis]
201 Cheng R, Liu C, Yang J, Yang Y, Chen R, Ding X, Gao X, Ke J, Yuan F, He C, Shen Y, Zhang L, Li P, Tan H, Huang L. Sex Differences in the Incidence and Risk Factors of Myocardial Injury in COVID-19 Patients: A Retrospective Cohort Study. Front Physiol 2021;12:632123. [PMID: 33664674 DOI: 10.3389/fphys.2021.632123] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
202 Xue M, Zeng Y, Qu HQ, Zhang T, Li N, Huang H, Zheng P, Hu H, Zhou L, Duan Z, Zhang Y, Bao W, Tian LF, Hakonarson H, Zhong N, Zhang XD, Sun B. Heparin-binding protein levels correlate with aggravation and multiorgan damage in severe COVID-19. ERJ Open Res 2021;7:00741-2020. [PMID: 33564671 DOI: 10.1183/23120541.00741-2020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
203 Pironti G, Andersson DC, Lund LH. Mechanistic and Therapeutic Implications of Extracellular Vesicles as a Potential Link Between Covid-19 and Cardiovascular Disease Manifestations. Front Cell Dev Biol 2021;9:640723. [PMID: 33644077 DOI: 10.3389/fcell.2021.640723] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
204 Crook RL, Williams H, Green M, Brown S, Morris R, Fletcher H, Walters S, Walsh C, Price A, King S, McAloon CJ. Prospective multicentre cohort study of transthoracic echocardiography provision in the South West of the UK during the first wave of SARS-CoV-2 pandemic. Open Heart 2021;8:e001409. [PMID: 33504630 DOI: 10.1136/openhrt-2020-001409] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
205 Zhang Y, Sun W, Wu C, Zhang Y, Cui L, Xie Y, Wang B, He L, Yuan H, Zhang Y, Cai Y, Li M, Zhang Y, Yang Y, Li Y, Wang J, Yang Y, Lv Q, Zhang L, Xie M. Prognostic Value of Right Ventricular Ejection Fraction Assessed by 3D Echocardiography in COVID-19 Patients. Front Cardiovasc Med 2021;8:641088. [PMID: 33634177 DOI: 10.3389/fcvm.2021.641088] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
206 Kopp S, Münzel T, Wenzel P. Endothel, vaskuläre Funktion und COVID-19. Aktuelle Kardiologie 2021;10:32-38. [DOI: 10.1055/a-1319-0964] [Reference Citation Analysis]
207 Ho MH, Liu JS. The swift knowledge development path of COVID-19 research: the first 150 days. Scientometrics 2021;:1-9. [PMID: 33551516 DOI: 10.1007/s11192-020-03835-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
208 Abd-alhameed R, Jamil MA, Ibrahim T, Qahwaji R, Rasheed M, Youseffi M. The Novel Coronavirus Causes Impairment of Blood Vessels and Respiratory System with Head-to-Toe Symptoms and Vaccine Development: An Overview. J Phys : Conf Ser 2021;1793:012055. [DOI: 10.1088/1742-6596/1793/1/012055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
209 Sönmez Topcu F, Yurtlu Temel Ş, Tutpinar Y. COVID-19 and Stroke. Black Sea Journal of Health Science 2021. [DOI: 10.19127/bshealthscience.844062] [Reference Citation Analysis]
210 Bieber S, Kraechan A, Hellmuth JC, Muenchhoff M, Scherer C, Schroeder I, Irlbeck M, Kaeaeb S, Massberg S, Hausleiter J, Grabmaier U, Orban M, Weckbach LT. Left and right ventricular dysfunction in patients with COVID-19-associated myocardial injury. Infection 2021;49:491-500. [PMID: 33515390 DOI: 10.1007/s15010-020-01572-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
211 Jounieaux V, Basille D, Abou-Arab O, Guillaumont MP, Andrejak C, Mahjoub Y, Rodenstein DO. Pure SARS-CoV-2 related AVDS (Acute Vascular Distress Syndrome). BMC Infect Dis 2021;21:122. [PMID: 33509109 DOI: 10.1186/s12879-021-05805-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
212 Sechi LA, Colussi G, Bulfone L, Brosolo G, Da Porto A, Peghin M, Patruno V, Tascini C, Catena C. Short-term cardiac outcome in survivors of COVID-19: a systematic study after hospital discharge. Clin Res Cardiol 2021;110:1063-72. [PMID: 33481096 DOI: 10.1007/s00392-020-01800-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
213 Perrone MA, Spolaore F, Ammirabile M, Romeo F, Caciagli P, Ceriotti F, Bernardini S. The assessment of high sensitivity cardiac troponin in patients with COVID-19: A multicenter study. Int J Cardiol Heart Vasc 2021;32:100715. [PMID: 33457490 DOI: 10.1016/j.ijcha.2021.100715] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
214 Mehta OP, Bhandari P, Raut A, Kacimi SEO, Huy NT. Coronavirus Disease (COVID-19): Comprehensive Review of Clinical Presentation. Front Public Health 2020;8:582932. [PMID: 33520910 DOI: 10.3389/fpubh.2020.582932] [Cited by in Crossref: 61] [Cited by in F6Publishing: 72] [Article Influence: 30.5] [Reference Citation Analysis]
215 Aboudounya MM, Heads RJ. COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation. Mediators Inflamm 2021;2021:8874339. [PMID: 33505220 DOI: 10.1155/2021/8874339] [Cited by in Crossref: 97] [Cited by in F6Publishing: 108] [Article Influence: 48.5] [Reference Citation Analysis]
216 Frazão M, da Cruz Santos A, de Assis Pereira Cacau L, Eugênio Silva P, Petrucci TR, Assis MC, de Almeida Leal R, de Moraes Forjaz CL, Brasileiro-santos MDS. Cardiorespiratory Fitness and Neuromuscular Performance in Patients Recovered from COVID-19.. [DOI: 10.1101/2021.01.11.20248930] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
217 Purvinsh L, Gorshkov A, Brodskaia A, Vasin A. Extracellular Vesicles in Viral Pathogenesis: A Case of Dr. Jekyll and Mr. Hyde. Life (Basel) 2021;11:45. [PMID: 33450847 DOI: 10.3390/life11010045] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
218 Patil R, Das B, Bhatia SY. Cardiac Biomarkers in Patients with COVID-19. Indian Journal of Medical Biochemistry 2021;24:43-49. [DOI: 10.5005/jp-journals-10054-0157] [Reference Citation Analysis]
219 Lee C, Choi WJ. Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective. Arch Pharm Res 2021;44:99-116. [PMID: 33398692 DOI: 10.1007/s12272-020-01301-7] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 19.5] [Reference Citation Analysis]
220 Schieffer E, Schieffer B, Hilfiker-Kleiner D. [Cardiovascular diseases and COVID-19 : Pathophysiology, complications and treatment]. Herz 2021;46:107-14. [PMID: 33394058 DOI: 10.1007/s00059-020-05013-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
221 Yang J, Chen T, Zhou Y. Mediators of SARS-CoV-2 entry are preferentially enriched in cardiomyocytes. Hereditas. 2021;158:4. [PMID: 33397514 DOI: 10.1186/s41065-020-00168-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
222 Al-shura AN. Cardiac cells. Mechanisms of Action in Disease and Recovery in Integrative Cardiovascular Chinese Medicine 2021. [DOI: 10.1016/b978-0-12-817578-1.00001-x] [Reference Citation Analysis]
223 Farouk AF, Shafqat A, Shafqat S, Kashir J, Alkattan K, Yaqinuddin A; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia, Medical College, Aga Khan University, Karachi, Pakistan, Department of Comparative Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. . AIMSMOLES 2021;8:275-90. [DOI: 10.3934/molsci.2021021] [Reference Citation Analysis]
224 Carr CT, Becker TK. COVID-19: Cardiac Arrest Management. Critical Care of COVID-19 in the Emergency Department 2021. [DOI: 10.1007/978-3-030-85636-6_8] [Reference Citation Analysis]
225 Kirubananthan L, Illuri R, Rajendran R, Chandrasekaran PR. Mechanism and transmission routes of COVID-19. Environmental and Health Management of Novel Coronavirus Disease (COVID-19 ) 2021. [DOI: 10.1016/b978-0-323-85780-2.00013-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
226 Hanifi M, Chibane H, Houssin R, Cavallucci D. IPG as a new method to improve the agility of the initial analysis of the inventive design. FME Transactions 2021;49:549-62. [DOI: 10.5937/fme2103549h] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
227 Goud PT, Bai D, Abu-Soud HM. A Multiple-Hit Hypothesis Involving Reactive Oxygen Species and Myeloperoxidase Explains Clinical Deterioration and Fatality in COVID-19. Int J Biol Sci 2021;17:62-72. [PMID: 33390833 DOI: 10.7150/ijbs.51811] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 15.5] [Reference Citation Analysis]
228 Li D, Ding X, Xie M, Tian D, Xia L. COVID-19-associated liver injury: from bedside to bench. J Gastroenterol 2021;56:218-30. [PMID: 33527211 DOI: 10.1007/s00535-021-01760-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 14.0] [Reference Citation Analysis]
229 Feldman S, Jang K, Smith D, Copeland-halperin RS. Cardio-Oncology in the COVID-19 Era. Atlas of Imaging in Cardio-Oncology 2021. [DOI: 10.1007/978-3-030-70998-3_31] [Reference Citation Analysis]
230 Khismatullina Z, Gumerov R, Aitova E, Kozireva L, Tyurin A, Pavlov V, Aminema A, Rakhmatullina E, Khabibullina I, Zagidullin N. Skin manifestations in severe COVID-19. Clinical case. Klin dermatol venerol 2021;20:46. [DOI: 10.17116/klinderma20212006146] [Reference Citation Analysis]
231 Marian AJ. Current state of vaccine development and targeted therapies for COVID-19: impact of basic science discoveries. Cardiovasc Pathol 2021;50:107278. [PMID: 32889088 DOI: 10.1016/j.carpath.2020.107278] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 21.5] [Reference Citation Analysis]
232 Вишнева ЕМ, Веснина НС. Ишемический инсульт и covid‑19: механизмы патогенеза, клинические характеристики и трудности лечения в условиях пандемии. Естественные и Технические Науки 2021. [DOI: 10.37882/2223-2966.2021.04.11] [Reference Citation Analysis]
233 Mazza A, Di Giorgio A, Martelli L, Pelliccia C, Pinotti MA, Quadri V, Verdoni L, Decio A, Ruggeri M, D'Antiga L. Patterns of Presentation of SARS-CoV-2 Infection in Children. Experience at the Italian Epicentre of the Pandemic. Front Pediatr 2021;9:629040. [PMID: 33585374 DOI: 10.3389/fped.2021.629040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
234 Sharma I, Sharma A, Kumari P. Plausible Impacts of SARS-CoV-2 on Human Reproductive System. Delineating Health and Health System: Mechanistic Insights into Covid 19 Complications 2021. [DOI: 10.1007/978-981-16-5105-2_23] [Reference Citation Analysis]
235 Fedele D, De Francesco A, Riso S, Collo A. Obesity, malnutrition, and trace element deficiency in the coronavirus disease (COVID-19) pandemic: An overview. Nutrition 2021;81:111016. [PMID: 33059127 DOI: 10.1016/j.nut.2020.111016] [Cited by in Crossref: 68] [Cited by in F6Publishing: 37] [Article Influence: 34.0] [Reference Citation Analysis]
236 Fonseca M, Summer R, Roman J. Acute Exacerbation of Interstitial Lung Disease as a Sequela of COVID-19 Pneumonia. Am J Med Sci 2021;361:126-9. [PMID: 32912600 DOI: 10.1016/j.amjms.2020.08.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
237 Hatmi ZN. A Systematic Review of Systematic Reviews on the COVID-19 Pandemic. SN Compr Clin Med 2021;3:419-36. [PMID: 33521564 DOI: 10.1007/s42399-021-00749-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 16.0] [Reference Citation Analysis]
238 Mfeukeu-kuate L, Ngatchou WD, Temgoua MN, Kouanfack C, Lemoungoum D, Tochie JN, Zemsi A, Fomete L, Lekelem S, Zemsi S, Sobngwi J, Ntandzi T, Ouankou CN, Wasnyo Y, Assiga AT, Nkeck JR, Jingi AM, Guewo M, Yone EWP, Omgba CM, Etoundi PO, Yombi JC, Kingue S, Menanga A, Minkande JZ, Zogo PO, Mbanya JC, Fouda PJ, Sobngwi E. Electrocardiographic Safety of Daily Hydroxychloroquine 400 mg Plus Azithromycin 250 mg as an Ambulatory Treatment for COVID-19 Patients in Cameroon. WJCD 2021;11:106-112. [DOI: 10.4236/wjcd.2021.112012] [Reference Citation Analysis]
239 Kaur S, Hasija Y. Role of Computational Intelligence Against COVID-19. Studies in Computational Intelligence 2021. [DOI: 10.1007/978-981-15-8534-0_2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
240 Lucreziotti S, Centola M, Barbieri L, Tumminello G, Conconi B, Gentile D, Carlà M, Salerno-uriarte D, Panzacchi G, Mafrici A, Carugo S. ST-segment elevation myocardial infarction care during the COVID-19 health emergency: the organization of one Hub center in Milan, Italy. Ital J Emerg Med 2021;9. [DOI: 10.23736/s2532-1285.20.00030-0] [Reference Citation Analysis]
241 Thompson S, Bohn M, Mancini N, Loh T, Wang C, Grimmler M, Yuen K, Mueller R, Koch D, Sethi, S, Rawlinson W, Clementi, M, Erasmus R, Leportier M, Kwon G, Menezes M, Patru M, Gramegna M, Singh K, Najjar O, Ferrari, M, Lippi G, Adeli, K, Horvath A. IFCC Interim Guidelines on Biochemical/ Hematological Monitoring of COVID-19 Patients. Lab sluzh 2021;10:55. [DOI: 10.17116/labs20211004155] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
242 Rezkalla SH, Kloner RA. Viral myocarditis: 1917-2020: From the Influenza A to the COVID-19 pandemics. Trends Cardiovasc Med 2021;31:163-9. [PMID: 33383171 DOI: 10.1016/j.tcm.2020.12.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
243 Cho JH, Namazi A, Shelton R, Ramireddy A, Ehdaie A, Shehata M, Wang X, Marbán E, Chugh SS, Cingolani E. Cardiac arrhythmias in hospitalized patients with COVID-19: A prospective observational study in the western United States. PLoS One 2020;15:e0244533. [PMID: 33370347 DOI: 10.1371/journal.pone.0244533] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
244 Sackner MA, Adams JA. Endothelial pulsatile shear stress is a backstop for COVID-19. Emerg Top Life Sci 2020;4:379-87. [PMID: 33200786 DOI: 10.1042/ETLS20200260] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
245 Karmakar D, Lahiri B, Ranjan P, Chatterjee J, Lahiri P, Sengupta S. Road Map to Understanding SARS-CoV-2 Clinico-Immunopathology and COVID-19 Disease Severity. Pathogens 2020;10:5. [PMID: 33374748 DOI: 10.3390/pathogens10010005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
246 Stubbs BJ, Koutnik AP, Goldberg EL, Upadhyay V, Turnbaugh PJ, Verdin E, Newman JC. Investigating Ketone Bodies as Immunometabolic Countermeasures against Respiratory Viral Infections. Med (N Y) 2020;1:43-65. [PMID: 32838361 DOI: 10.1016/j.medj.2020.06.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
247 Strafella C, Caputo V, Termine A, Barati S, Caltagirone C, Giardina E, Cascella R. Investigation of Genetic Variations of IL6 and IL6R as Potential Prognostic and Pharmacogenetics Biomarkers: Implications for COVID-19 and Neuroinflammatory Disorders. Life (Basel) 2020;10:E351. [PMID: 33339153 DOI: 10.3390/life10120351] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
248 Kingstone T, Taylor AK, O'Donnell CA, Atherton H, Blane DN, Chew-Graham CA. Finding the 'right' GP: a qualitative study of the experiences of people with long-COVID. BJGP Open 2020;4:bjgpopen20X101143. [PMID: 33051223 DOI: 10.3399/bjgpopen20X101143] [Cited by in Crossref: 95] [Cited by in F6Publishing: 93] [Article Influence: 31.7] [Reference Citation Analysis]
249 Metogo JAM, Tochie JN, Etoundi PO, Bengono RSB, Ndikontar R, Minkande JZ. Anaesthesiologist-intensivist phycisians at the core of the management of critically ill COVID-19 patients in Africa: persistent challenges, some resolved dilemma and future perspective. Pan Afr Med J 2020;37:44. [PMID: 33552372 DOI: 10.11604/pamj.supp.2020.37.44.25234] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
250 Bienvenu LA, Noonan J, Wang X, Peter K. Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities. Cardiovasc Res 2020;116:2197-206. [PMID: 33063089 DOI: 10.1093/cvr/cvaa284] [Cited by in Crossref: 99] [Cited by in F6Publishing: 110] [Article Influence: 33.0] [Reference Citation Analysis]
251 Dorjee K, Kim H, Bonomo E, Dolma R. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients. PLoS One 2020;15:e0243191. [PMID: 33284825 DOI: 10.1371/journal.pone.0243191] [Cited by in Crossref: 98] [Cited by in F6Publishing: 107] [Article Influence: 32.7] [Reference Citation Analysis]
252 Maiuolo J, Mollace R, Gliozzi M, Musolino V, Carresi C, Paone S, Scicchitano M, Macrì R, Nucera S, Bosco F, Scarano F, Zito MC, Ruga S, Tavernese A, Mollace V. The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection. Int J Mol Sci 2020;21:E9309. [PMID: 33291346 DOI: 10.3390/ijms21239309] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
253 Degarege A, Naveed Z, Kabayundo J, Brett-major D. Risk factors for severe illness and death in COVID-19: a systematic review and meta-analysis.. [DOI: 10.1101/2020.12.03.20243659] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
254 Chengyi HU, Lushan X, Hongbo Z, Yanpei Z, Wenfeng Z, Li L, Hong Z. [Effect of hypertension on outcomes of patients with COVID-19]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:1537-42. [PMID: 33243750 DOI: 10.12122/j.issn.1673-4254.2020.11.01] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
255 Salamanna F, Maglio M, Landini MP, Fini M. Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2. Front Med (Lausanne) 2020;7:594495. [PMID: 33344479 DOI: 10.3389/fmed.2020.594495] [Cited by in Crossref: 80] [Cited by in F6Publishing: 87] [Article Influence: 26.7] [Reference Citation Analysis]
256 Idhrees AM, Suthakaran PK, Valooran GJ, Bashir M. Will Remdesivir Reshape Cardiovascular Practice in COVID 19 Era? Int J Angiol 2021;30:155-9. [PMID: 34054274 DOI: 10.1055/s-0040-1721403] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
257 Dos Anjos F, Simões JLB, Assmann CE, Carvalho FB, Bagatini MD. Potential Therapeutic Role of Purinergic Receptors in Cardiovascular Disease Mediated by SARS-CoV-2. J Immunol Res 2020;2020:8632048. [PMID: 33299899 DOI: 10.1155/2020/8632048] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
258 Thakkar S, Arora S, Kumar A, Jaswaney R, Faisaluddin M, Ammad Ud Din M, Shariff M, Barssoum K, Patel HP, Nirav A, Jani C, Patel K, Savani S, DeSimone C, Mulpuru S, Deshmukh A. A Systematic Review of the Cardiovascular Manifestations and Outcomes in the Setting of Coronavirus-19 Disease. Clin Med Insights Cardiol 2020;14:1179546820977196. [PMID: 33312009 DOI: 10.1177/1179546820977196] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
259 Laptev D, Petunov S, Nechaykina O, Bobkov D, Radilov A. Using experimental ex vivo models to develop COVID-19 pathogenetic therapy and complications prevention agents. MES 2020. [DOI: 10.47183/mes.2020.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
260 Nowak BM, Kamiński M. The Productivity of Medical Publication on COVID-19 in the First Half of 2020: A Retrospective Analysis of Articles Available in PubMed. Cureus 2020;12:e11814. [PMID: 33409059 DOI: 10.7759/cureus.11814] [Reference Citation Analysis]
261 Zareef RO, Younis NK, Bitar F, Eid AH, Arabi M. COVID-19 in Pediatric Patients: A Focus on CHD Patients. Front Cardiovasc Med 2020;7:612460. [PMID: 33330675 DOI: 10.3389/fcvm.2020.612460] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
262 Kanthasamy V, Schilling RJ. Electrophysiology in the Era of Coronavirus Disease 2019. Arrhythm Electrophysiol Rev 2020;9:167-70. [PMID: 33240513 DOI: 10.15420/aer.2020.32] [Reference Citation Analysis]
263 Iqbal QZ, Haider MA, Sattar SBA, Hanif M, Javid I. COVID-19 Induced Myocarditis: A Rare Cause of Heart Failure. Cureus 2020;12:e11690. [PMID: 33391924 DOI: 10.7759/cureus.11690] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
264 Mu S, Wei W, Jin C, Pu N, Yu K, Gu G, Luo Z, Tong C, Han Y. Risk factors for COVID-19 patients with cardiac injury: pulmonary ventilation dysfunction and oxygen inhalation insufficiency are not the direct causes. Aging (Albany NY) 2020;12:23464-77. [PMID: 33226958 DOI: 10.18632/aging.104148] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
265 Grzegorowska O, Lorkowski J. Possible Correlations between Atherosclerosis, Acute Coronary Syndromes and COVID-19. J Clin Med 2020;9:E3746. [PMID: 33233333 DOI: 10.3390/jcm9113746] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
266 Bois MC, Boire NA, Layman AJ, Aubry MC, Alexander MP, Roden AC, Hagen CE, Quinton RA, Larsen C, Erben Y, Majumdar R, Jenkins SM, Kipp BR, Lin PT, Maleszewski JJ. COVID-19-Associated Nonocclusive Fibrin Microthrombi in the Heart. Circulation 2021;143:230-43. [PMID: 33197204 DOI: 10.1161/CIRCULATIONAHA.120.050754] [Cited by in Crossref: 77] [Cited by in F6Publishing: 81] [Article Influence: 25.7] [Reference Citation Analysis]
267 Bigdelian H, Sedighi M, Sabri MR, Dehghan B, Pourmoghaddas Z, Saleh R, Sherafat A, Massoumi G, Rezaei MK, Shahbazi M. Right Atrial Thrombus in a COVID-19 Child Treated Through Cardiac Surgery. Front Cardiovasc Med 2020;7:579522. [PMID: 33263006 DOI: 10.3389/fcvm.2020.579522] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
268 Limanaqi F, Busceti CL, Biagioni F, Lazzeri G, Forte M, Schiavon S, Sciarretta S, Frati G, Fornai F. Cell Clearing Systems as Targets of Polyphenols in Viral Infections: Potential Implications for COVID-19 Pathogenesis.Antioxidants (Basel). 2020;9:1105. [PMID: 33182802 DOI: 10.3390/antiox9111105] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
269 Sirvent JM, Baro A, Morales M, Sebastian P, Saiz X. Predictive biomarkers of mortality in critically ill patients with COVID-19. Med Intensiva (Engl Ed) 2020:S0210-5691(20)30334-X. [PMID: 33309108 DOI: 10.1016/j.medin.2020.09.010] [Reference Citation Analysis]
270 Amendola A, Garoffolo G, Songia P, Ferrari S, Bernava G, Canzano P, Myasoedova V, Colavita F, Castilletti C, Sberna G, Capobianchi MR, Agrifoglio M, Colombo GI, Poggio P, Pesce M. Human cardiac stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 receptor expression.. [DOI: 10.1101/2020.11.06.20226423] [Reference Citation Analysis]
271 Parisi N, Janier-dubry A, Ponzetto E, Pavlopoulos C, Bakalli G, Molinari R, Guerrier S, Mili N. Non applicability of validated predictive models for intensive care admission and death of COVID-19 patients in a secondary care hospital in Belgium.. [DOI: 10.1101/2020.11.06.20205799] [Reference Citation Analysis]
272 Ojo AS, Balogun SA, Idowu AO. Acute Ischemic Stroke in COVID-19: Putative Mechanisms, Clinical Characteristics, and Management. Neurol Res Int 2020;2020:7397480. [PMID: 33224529 DOI: 10.1155/2020/7397480] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
273 Volis I, Livneh I, Hussein K, Raz-Pasteur A. COVID-19-Associated Suspected Myocarditis as the Etiology for Recurrent and Protracted Fever in an Otherwise Healthy Adult. Am J Med Sci 2021;361:522-5. [PMID: 33546881 DOI: 10.1016/j.amjms.2020.11.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
274 Bertolini A, van de Peppel IP, Bodewes FAJA, Moshage H, Fantin A, Farinati F, Fiorotto R, Jonker JW, Strazzabosco M, Verkade HJ, Peserico G. Abnormal Liver Function Tests in Patients With COVID-19: Relevance and Potential Pathogenesis. Hepatology 2020;72:1864-72. [PMID: 32702162 DOI: 10.1002/hep.31480] [Cited by in Crossref: 170] [Cited by in F6Publishing: 174] [Article Influence: 56.7] [Reference Citation Analysis]
275 Azpaiazu Landa N, Velasco Oficialdegui C, Intxaurraga Fernández K, Gonzalez Larrabe I, Riaño Onaindia S, Telletxea Benguria S. Ischemic-hemorrhagic stroke in patients with Covid-19. Revista Española de Anestesiología y Reanimación (English Edition) 2020;67:516-520. [DOI: 10.1016/j.redare.2020.08.001] [Reference Citation Analysis]
276 Greco S, Madè A, Gaetano C, Devaux Y, Emanueli C, Martelli F. Noncoding RNAs implication in cardiovascular diseases in the COVID-19 era. J Transl Med 2020;18:408. [PMID: 33129318 DOI: 10.1186/s12967-020-02582-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
277 Sriram K, Insel PA. Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets. Physiol Rev 2021;101:545-67. [PMID: 33124941 DOI: 10.1152/physrev.00035.2020] [Cited by in Crossref: 45] [Cited by in F6Publishing: 53] [Article Influence: 15.0] [Reference Citation Analysis]
278 Biscetti F, Rando MM, Nardella E, Cecchini AL, Bruno P, Landolfi R, Flex A. Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury. Int J Mol Sci 2020;21:E8141. [PMID: 33143371 DOI: 10.3390/ijms21218141] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
279 Doyen D, Dupland P, Morand L, Fourrier E, Saccheri C, Buscot M, Hyvernat H, Ferrari E, Bernardin G, Cariou A, Mira JP, Jamme M, Dellamonica J, Jozwiak M. Characteristics of Cardiac Injury in Critically Ill Patients With Coronavirus Disease 2019. Chest 2021;159:1974-85. [PMID: 33129792 DOI: 10.1016/j.chest.2020.10.056] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
280 Gonçalves ED, Justiniano ALM, Freitas CDCE, Abrame ÉES, Reinaldi JRF, Matos LRD. Farmacoterapia aplicada à COVID-19. Revista Científica Multidisciplinar Núcleo do Conhecimento 2020. [DOI: 10.32749/nucleodoconhecimento.com.br/saude/farmacoterapia] [Reference Citation Analysis]
281 Zhou W, Song L, Wang X, Xu Z, Wang S, Wang J, Xu H, Zheng Y, Wang Y. Cardiac injury prediction and lymphocyte immunity and inflammation analysis in hospitalized patients with coronavirus disease 2019 (COVID-19). Int J Cardiol 2021;326:237-42. [PMID: 33098952 DOI: 10.1016/j.ijcard.2020.10.049] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
282 De Lorenzo R, Conte C, Lanzani C, Benedetti F, Roveri L, Mazza MG, Brioni E, Giacalone G, Canti V, Sofia V, D'Amico M, Di Napoli D, Ambrosio A, Scarpellini P, Castagna A, Landoni G, Zangrillo A, Bosi E, Tresoldi M, Ciceri F, Rovere-Querini P. Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study. PLoS One 2020;15:e0239570. [PMID: 33052920 DOI: 10.1371/journal.pone.0239570] [Cited by in Crossref: 83] [Cited by in F6Publishing: 88] [Article Influence: 27.7] [Reference Citation Analysis]
283 Almarawi HA, Alwani MM, Arabi A. Right Ventricular Involvement in COVID-19 Patients: A Rapid Review. Heart Views 2020;21:193-4. [PMID: 33688411 DOI: 10.4103/HEARTVIEWS.HEARTVIEWS_160_20] [Reference Citation Analysis]
284 Kim IC, Song JE, Lee HJ, Park JH, Hyun M, Lee JY, Kim HA, Kwon YS, Park JS, Youn JC, Hwang J, Lee CH, Cho YK, Park HS, Yoon HJ, Nam CW, Han S, Hur SH, Eisen HJ, Kim H. The Implication of Cardiac Injury Score on In-hospital Mortality of Coronavirus Disease 2019. J Korean Med Sci 2020;35:e349. [PMID: 33045772 DOI: 10.3346/jkms.2020.35.e349] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
285 Abdeladim S, Oualim S, Elouarradi A, Bensahi I, Aniq Filali R, El Harras M, Scadi S, Bouaiti EA, Abdelhamid N, Sabry M. Analysis of Cardiac Injury Biomarkers in COVID-19 Patients. Arch Clin Infect Dis 2020;15. [DOI: 10.5812/archcid.105515] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
286 Fard D, Huguet R, Koutsoukis A, Deguillard C, Tuffreau AS, Deux JF, Lim P, Teiger E. [SARS-COV-2 myocarditis. An update]. Ann Cardiol Angeiol (Paris) 2020;69:349-54. [PMID: 33069383 DOI: 10.1016/j.ancard.2020.10.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
287 Fan Q, Zhu H, Zhao J, Zhuang L, Zhang H, Xie H, Zhang R, Granada JF, Xiang X, Hu W, Yan X. Risk factors for myocardial injury in patients with coronavirus disease 2019 in China. ESC Heart Fail 2020. [PMID: 33006440 DOI: 10.1002/ehf2.13022] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
288 Azpiazu Landa N, Velasco Oficialdegui C, Intxaurraga Fernández K, Gonzalez Larrabe I, Riaño Onaindia S, Telletxea Benguria S. Ischemic-hemorrhagic stroke in patients with Covid-19. Rev Esp Anestesiol Reanim (Engl Ed) 2020;67:516-20. [PMID: 33012537 DOI: 10.1016/j.redar.2020.08.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
289 Cho J, Lee YJ, Kim JH, Kim SI, Kim SS, Choi BS, Choi JH. Antiviral activity of digoxin and ouabain against SARS-CoV-2 infection and its implication for COVID-19. Sci Rep 2020;10:16200. [PMID: 33004837 DOI: 10.1038/s41598-020-72879-7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 14.7] [Reference Citation Analysis]
290 Fernández-sarmiento J, Acevedo L, Mulett H, Bastidas S, Sarta M, Durán N, Chacón S, Bejarano-quintero AM, Mizar O, Pérez A, Uribe-londoño J. Severe SARS-CoV-2 infection in critical care. Trends in Anaesthesia and Critical Care 2020;34:28-37. [DOI: 10.1016/j.tacc.2020.07.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
291 Sadler C, Alvarez Villela M, Van Hoesen K, Grover I, Lang M, Neuman T, Lindholm P. Diving after SARS-CoV-2 (COVID-19) infection: Fitness to dive assessment and medical guidance. Diving Hyperb Med 2020;50:278-87. [PMID: 32957131 DOI: 10.28920/dhm50.3.278-287] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
292 Subramaniam MD, Venkatesan D, Iyer M, Subbarayan S, Govindasami V, Roy A, Narayanasamy A, Kamalakannan S, Gopalakrishnan AV, Thangarasu R, Kumar NS, Vellingiri B. Biosurfactants and anti-inflammatory activity: A potential new approach towards COVID-19. Curr Opin Environ Sci Health 2020;17:72-81. [PMID: 33015428 DOI: 10.1016/j.coesh.2020.09.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
293 Sparks MA, South AM, Badley AD, Baker-Smith CM, Batlle D, Bozkurt B, Cattaneo R, Crowley SD, Dell'Italia LJ, Ford AL, Griendling K, Gurley SB, Kasner SE, Murray JA, Nath KA, Pfeffer MA, Rangaswami J, Taylor WR, Garovic VD. Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System: Pressing Needs and Best Research Practices. Hypertension 2020;76:1350-67. [PMID: 32981369 DOI: 10.1161/HYPERTENSIONAHA.120.15948] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 12.0] [Reference Citation Analysis]
294 Oxford AE, Halla F, Robertson EB, Morrison BE. Endothelial Cell Contributions to COVID-19. Pathogens 2020;9:E785. [PMID: 32992810 DOI: 10.3390/pathogens9100785] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
295 Scimeca M, Urbano N, Bonfiglio R, Montanaro M, Bonanno E, Schillaci O, Mauriello A. Imaging Diagnostics and Pathology in SARS-CoV-2-Related Diseases. Int J Mol Sci 2020;21:E6960. [PMID: 32971906 DOI: 10.3390/ijms21186960] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
296 Hatami F, Valizadeh N, Ansari Ramandi MM. Emerging mechanisms for the new coronavirus-related myocardial injury and ischemia: A review of the literature. Anatol J Cardiol 2020;24:7-12. [PMID: 32628143 DOI: 10.14744/AnatolJCardiol.2020.68166] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
297 Reisin R, Rozenfeld P, Bonardo P. Fabry disease patients have an increased risk of stroke in the COVID-19 ERA. A hypothesis. Medical Hypotheses 2020;144:110282. [DOI: 10.1016/j.mehy.2020.110282] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
298 Feldman C, Anderson R. Brief review: Cardiac complications and platelet activation in COVID-19 infection. Afr J Thorac Crit Care Med 2020;26. [PMID: 34235425 DOI: 10.7196/AJTCCM.2020.v26i3.107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
299 Ye Q, Lu D, Shang S, Fu J, Gong F, Shu Q, Mao J. Crosstalk between coronavirus disease 2019 and cardiovascular disease and its treatment. ESC Heart Fail 2020. [PMID: 32935928 DOI: 10.1002/ehf2.12960] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
300 Ghanchi H, Patchana T, Wiginton J 4th, Browne JD, Ohno A, Farahmandian R, Duong J, Cortez V, Miulli DE. Racial Disparity Amongst Stroke Patients During the Coronavirus Disease 2019 Pandemic. Cureus 2020;12:e10369. [PMID: 33062492 DOI: 10.7759/cureus.10369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
301 Estrada E. Fractional diffusion on the human proteome as an alternative to the multi-organ damage of SARS-CoV-2. Chaos 2020;30:081104. [PMID: 32872802 DOI: 10.1063/5.0015626] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
302 Mavraganis G, Aivalioti E, Chatzidou S, Patras R, Paraskevaidis I, Kanakakis I, Stamatelopoulos K, Dimopoulos MA. Cardiac arrest and drug-related cardiac toxicity in the Covid-19 era. Epidemiology, pathophysiology and management. Food Chem Toxicol 2020;145:111742. [PMID: 32916218 DOI: 10.1016/j.fct.2020.111742] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
303 Maev IV, Shpektor AV, Vasilyeva EY, Manchurov VN, Andreev DN. [Novel coronavirus infection COVID-19: extrapulmonary manifestations]. Ter Arkh 2020;92:4-11. [PMID: 33346454 DOI: 10.26442/00403660.2020.08.000767] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
304 Shi W, Lv J, Lin L. Coagulopathy in COVID-19: Focus on vascular thrombotic events. J Mol Cell Cardiol 2020;146:32-40. [PMID: 32681845 DOI: 10.1016/j.yjmcc.2020.07.003] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 12.3] [Reference Citation Analysis]
305 Dehghani P, Davidson LJ, Grines CL, Nayak K, Saw J, Kaul P, Bagai A, Garberich R, Schmidt C, Ly HQ, Giri J, Meraj P, Shah B, Garcia S, Sharkey S, Wood DA, Welt FG, Mahmud E, Henry TD. North American COVID-19 ST-Segment-Elevation Myocardial Infarction (NACMI) registry: Rationale, design, and implications. Am Heart J 2020;227:11-8. [PMID: 32425198 DOI: 10.1016/j.ahj.2020.05.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
306 Danwang C, Endomba FT, Nkeck JR, Wouna DLA, Robert A, Noubiap JJ. A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19). Biomark Res 2020;8:37. [PMID: 32879731 DOI: 10.1186/s40364-020-00217-0] [Cited by in Crossref: 76] [Cited by in F6Publishing: 80] [Article Influence: 25.3] [Reference Citation Analysis]
307 Gomila-Grange A, Espasa M, Moglia E. Cardiogenic Shock Caused by SARS-CoV-2 in a Patient with Serial Negative Nucleic Acid Amplification Tests. Case Report. SN Compr Clin Med 2020;:1-3. [PMID: 32904594 DOI: 10.1007/s42399-020-00496-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
308 Soeiro AM, Leal TCAT, Pereira MP, Lima EG, Figueiredo ACBDS, Petriz JLF, Precoma DB, Serrano CV Jr. Position Statement on the Use of Antiplatelet Agents and Anticoagulants in Patients Infected with the New Coronavirus (COVID-19) - 2020. Arq Bras Cardiol 2020;115:292-301. [PMID: 32876200 DOI: 10.36660/abc.20200424] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
309 Faqihi F, Alharthy A, Alshaya R, Papanikolaou J, Kutsogiannis DJ, Brindley PG, Karakitsos D. Reverse takotsubo cardiomyopathy in fulminant COVID-19 associated with cytokine release syndrome and resolution following therapeutic plasma exchange: a case-report. BMC Cardiovasc Disord 2020;20:389. [PMID: 32842957 DOI: 10.1186/s12872-020-01665-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
310 Gardin C, Ferroni L, Chachques JC, Zavan B. Could Mesenchymal Stem Cell-Derived Exosomes Be a Therapeutic Option for Critically Ill COVID-19 Patients? J Clin Med 2020;9:E2762. [PMID: 32858940 DOI: 10.3390/jcm9092762] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
311 Lukiw WJ, Pogue A, Hill JM. SARS-CoV-2 Infectivity and Neurological Targets in the Brain. Cell Mol Neurobiol 2020. [PMID: 32840758 DOI: 10.1007/s10571-020-00947-7] [Cited by in Crossref: 67] [Cited by in F6Publishing: 78] [Article Influence: 22.3] [Reference Citation Analysis]
312 George PM, Barratt SL, Condliffe R, Desai SR, Devaraj A, Forrest I, Gibbons MA, Hart N, Jenkins RG, McAuley DF, Patel BV, Thwaite E, Spencer LG. Respiratory follow-up of patients with COVID-19 pneumonia. Thorax 2020;75:1009-16. [PMID: 32839287 DOI: 10.1136/thoraxjnl-2020-215314] [Cited by in Crossref: 173] [Cited by in F6Publishing: 179] [Article Influence: 57.7] [Reference Citation Analysis]
313 Medzikovic L, Cunningham CM, Li M, Amjedi M, Hong J, Ruffenach G, Eghbali M. Sex differences underlying preexisting cardiovascular disease and cardiovascular injury in COVID-19. J Mol Cell Cardiol 2020;148:25-33. [PMID: 32835666 DOI: 10.1016/j.yjmcc.2020.08.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
314 Grewal P, Pinna P, Hall JP, Dafer RM, Tavarez T, Pellack DR, Garg R, Osteraas ND, Vargas A, John S, Da Silva I, Conners JJ. Acute Ischemic Stroke and COVID-19: Experience From a Comprehensive Stroke Center in Midwest US. Front Neurol 2020;11:910. [PMID: 32973666 DOI: 10.3389/fneur.2020.00910] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
315 Moore JT, Pilkington W, Kumar D. Diseases with health disparities as drivers of COVID-19 outcome. J Cell Mol Med 2020;24:11038-45. [PMID: 32816409 DOI: 10.1111/jcmm.15599] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
316 Smeda M, Chlopicki S. Endothelial barrier integrity in COVID-19-dependent hyperinflammation: does the protective facet of platelet function matter? Cardiovasc Res 2020;116:e118-21. [PMID: 32707576 DOI: 10.1093/cvr/cvaa190] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
317 Sirotkin K, Sirotkin D. Might SARS-CoV-2 Have Arisen via Serial Passage through an Animal Host or Cell Culture?: A potential explanation for much of the novel coronavirus' distinctive genome. Bioessays 2020;42:e2000091. [PMID: 32786014 DOI: 10.1002/bies.202000091] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
318 Thakkar S, Arora S, Kumar A, Jaswaney R, Faisaluddin M, Ammad Ud Din M, Shariff M, Barssoum K, Patel HP, Nirav A, Jani C, Savani S, Desimone C, Mulpuru S, Deshmukh A. A Systematic Review of the Cardiovascular Manifestations and Outcomes in the Setting of Coronavirus-19 Disease.. [DOI: 10.1101/2020.08.09.20171330] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
319 Kohli U, Lodha R. Cardiac Involvement in Children With COVID-19. Indian Pediatr 2020;57:936-9. [PMID: 32769232 [PMID: 32769232 DOI: 10.1007/s13312-020-1998-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
320 Knowlton KU. Pathogenesis of SARS-CoV-2 induced cardiac injury from the perspective of the virus. J Mol Cell Cardiol 2020;147:12-7. [PMID: 32771409 DOI: 10.1016/j.yjmcc.2020.08.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
321 Weenink RP, Preckel B, Hulst AH, Hermanides J, de Jong MD, Schlack WS, Stevens MF, Sperna Weiland NH, Hollmann MW. Second Update for Anaesthetists on Clinical Features of COVID-19 Patients and Relevant Management. J Clin Med 2020;9:E2542. [PMID: 32781614 DOI: 10.3390/jcm9082542] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
322 Pradhan RR, Yadav AK, Mandal S. Cardiovascular implications of coronavirus disease 2019: a systematic review. F1000Res 2020;9:899. [DOI: 10.12688/f1000research.25211.1] [Reference Citation Analysis]
323 Jain U. Effect of COVID-19 on the Organs. Cureus 2020;12:e9540. [PMID: 32905500 DOI: 10.7759/cureus.9540] [Cited by in Crossref: 38] [Cited by in F6Publishing: 49] [Article Influence: 12.7] [Reference Citation Analysis]
324 Figueira Gonçalves JM, Golpe R. Clinical challenges in chronic obstructive pulmonary disease in patients who suffered SARS-CoV-2 infection. Medicina Clínica (English Edition) 2020;155:162-164. [DOI: 10.1016/j.medcle.2020.04.012] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
325 Gemelli Against COVID-19 Post-Acute Care Study Group. Post-COVID-19 global health strategies: the need for an interdisciplinary approach. Aging Clin Exp Res 2020;32:1613-20. [PMID: 32529595 DOI: 10.1007/s40520-020-01616-x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 103] [Article Influence: 29.7] [Reference Citation Analysis]
326 Yang H, Zhong F. Comorbidities associated with regional variations in COVID-19 mortality revealed by population-level analysis.. [DOI: 10.1101/2020.07.27.20158105] [Reference Citation Analysis]
327 Addison D, Campbell CM, Guha A, Ghosh AK, Dent SF, Jneid H. Cardio-Oncology in the Era of the COVID-19 Pandemic and Beyond. J Am Heart Assoc 2020;9:e017787. [PMID: 32713239 DOI: 10.1161/JAHA.120.017787] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
328 Moriarty PM, Gorby LK, Stroes ES, Kastelein JP, Davidson M, Tsimikas S. Lipoprotein(a) and Its Potential Association with Thrombosis and Inflammation in COVID-19: a Testable Hypothesis. Curr Atheroscler Rep 2020;22:48. [PMID: 32710255 DOI: 10.1007/s11883-020-00867-3] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 14.3] [Reference Citation Analysis]
329 Nganou-gnindjio CN, Temgoua MN, Kuate LM, Nkoke C, Tochie JN, Ndobo-kue V, Owona-nsiaguam A, Boombhi J, Kipenge R, Huba U, Kane M, el Jirari MT, Ndongo-amougou S, Hamadou B, Menanga A, Kingue S. A multinational e-survey on the delivery of cardiology services in Africa during the COVID-19 pandemic: what should we expect after this pandemic?. [DOI: 10.1101/2020.07.24.20160390] [Reference Citation Analysis]
330 Rudski L, Januzzi JL, Rigolin VH, Bohula EA, Blankstein R, Patel AR, Bucciarelli-Ducci C, Vorovich E, Mukherjee M, Rao SV, Beanlands R, Villines TC, Di Carli MF; Expert Panel From the ACC Cardiovascular Imaging Leadership Council. Multimodality Imaging in Evaluation of Cardiovascular Complications in Patients With COVID-19: JACC Scientific Expert Panel. J Am Coll Cardiol 2020;76:1345-57. [PMID: 32710927 DOI: 10.1016/j.jacc.2020.06.080] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 12.7] [Reference Citation Analysis]
331 Song X, Hu W, Yu H, Zhao L, Zhao Y, Zhao Y. High expression of angiotensin-converting enzyme-2 (ACE2) on tissue macrophages that may be targeted by virus SARS-CoV-2 in COVID-19 patients.. [DOI: 10.1101/2020.07.18.210120] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
332 Kadosh BS, Garshick MS, Gaztanaga J, Moore KJ, Newman JD, Pillinger M, Ramasamy R, Reynolds HR, Shah B, Hochman J, Fishman GI, Katz SD. COVID-19 and the Heart and Vasculature: Novel Approaches to Reduce Virus-Induced Inflammation in Patients With Cardiovascular Disease. Arterioscler Thromb Vasc Biol 2020;40:2045-53. [PMID: 32687400 DOI: 10.1161/ATVBAHA.120.314513] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
333 Spence JD, de Freitas GR, Pettigrew LC, Ay H, Liebeskind DS, Kase CS, Del Brutto OH, Hankey GJ, Venketasubramanian N. Mechanisms of Stroke in COVID-19. Cerebrovasc Dis 2020;49:451-8. [PMID: 32690850 DOI: 10.1159/000509581] [Cited by in Crossref: 114] [Cited by in F6Publishing: 120] [Article Influence: 38.0] [Reference Citation Analysis]
334 de Vries AAF. SARS-CoV-2/COVID-19: a primer for cardiologists. Neth Heart J 2020;28:366-83. [PMID: 32671650 DOI: 10.1007/s12471-020-01475-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
335 Iacobazzi D, Baquedano M, Madeddu P, Caputo M. COVID-19, State of the Adult and Pediatric Heart: From Myocardial Injury to Cardiac Effect of Potential Therapeutic Intervention. Front Cardiovasc Med 2020;7:140. [PMID: 32760740 DOI: 10.3389/fcvm.2020.00140] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
336 Qin JJ, Cheng X, Zhou F, Lei F, Akolkar G, Cai J, Zhang XJ, Blet A, Xie J, Zhang P, Liu YM, Huang Z, Zhao LP, Lin L, Xia M, Chen MM, Song X, Bai L, Chen Z, Zhang X, Xiang D, Chen J, Xu Q, Ma X, Touyz RM, Gao C, Wang H, Liu L, Mao W, Luo P, Yan Y, Ye P, Chen M, Chen G, Zhu L, She ZG, Huang X, Yuan Y, Zhang BH, Wang Y, Liu PP, Li H. Redefining Cardiac Biomarkers in Predicting Mortality of Inpatients With COVID-19. Hypertension 2020;76:1104-12. [PMID: 32673499 DOI: 10.1161/HYPERTENSIONAHA.120.15528] [Cited by in Crossref: 91] [Cited by in F6Publishing: 97] [Article Influence: 30.3] [Reference Citation Analysis]
337 Belopasov VV, Samoilova EM, Baklaushev VP. THE NERVOUS SYSTEM DAMAGE IN COVID-19 PATIENTS. Journal of Clinical Practice. [DOI: 10.17816/clinpract34851] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 9.7] [Reference Citation Analysis]
338 Awad WI, Idhrees M, Kennon S, Bashir M. Coronary artery bypass grafting surgery versus percutaneous coronary intervention: What is the clinical decision framework amid COVID-19 era? J Card Surg 2020;35:2464-6. [PMID: 32652722 DOI: 10.1111/jocs.14833] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
339 Radmard S, Epstein SE, Roeder HJ, Michalak AJ, Shapiro SD, Boehme A, Wilson TJ, Duran JC, Bain JM, Willey JZ, Thakur KT. Inpatient Neurology Consultations During the Onset of the SARS-CoV-2 New York City Pandemic: A Single Center Case Series. Front Neurol 2020;11:805. [PMID: 32754113 DOI: 10.3389/fneur.2020.00805] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
340 Wang BX. Susceptibility and prognosis of COVID-19 patients with cardiovascular disease. Open Heart 2020;7:e001310. [PMID: 32587104 DOI: 10.1136/openhrt-2020-001310] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
341 Parekh M, Donuru A, Balasubramanya R, Kapur S. Review of the Chest CT Differential Diagnosis of Ground-Glass Opacities in the COVID Era. Radiology. 2020;297:E289-E302. [PMID: 32633678 DOI: 10.1148/radiol.2020202504] [Cited by in Crossref: 68] [Cited by in F6Publishing: 72] [Article Influence: 22.7] [Reference Citation Analysis]
342 Schönrich G, Raftery MJ, Samstag Y. Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression. Adv Biol Regul 2020;77:100741. [PMID: 32773102 DOI: 10.1016/j.jbior.2020.100741] [Cited by in Crossref: 112] [Cited by in F6Publishing: 118] [Article Influence: 37.3] [Reference Citation Analysis]
343 Labò N, Ohnuki H, Tosato G. Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection. Cells 2020;9:E1583. [PMID: 32629875 DOI: 10.3390/cells9071583] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 16.7] [Reference Citation Analysis]
344 Ayres JS. A metabolic handbook for the COVID-19 pandemic.Nat Metab. 2020;2:572-585. [PMID: 32694793 DOI: 10.1038/s42255-020-0237-2] [Cited by in Crossref: 154] [Cited by in F6Publishing: 157] [Article Influence: 51.3] [Reference Citation Analysis]
345 Mfeukeu-kuate L, Ngatchou W, Temgoua MN, Kouanfack C, Lemogoum D, Tochie JN, Zemsi A, Fomete L, Lekelem S, Zemsi S, Sobngwi J, Ntandzi T, Ouankou CN, Wasnyo Y, Assiga AN, Nkeck JR, Jingi AM, Guewo M, Pefura Yone EW, Omgba CM, Etoundi PO, Yombi JC, Menanga A, Kingue S, Minkande JZ, Mbanya JC, Zogo PO, Fouda PJ, Sobngwi E. Electrocardiographic safety of daily Hydroxychloroquine 400mg plus Azithromycin 250mg as an ambulatory treatment for COVID-19 patients in Cameroon.. [DOI: 10.1101/2020.06.24.20139386] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
346 Mitrani RD, Dabas N, Goldberger JJ. COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors. Heart Rhythm. 2020;17:1984-1990. [PMID: 32599178 DOI: 10.1016/j.hrthm.2020.06.026] [Cited by in Crossref: 148] [Cited by in F6Publishing: 158] [Article Influence: 49.3] [Reference Citation Analysis]
347 Yang M, Li H, Sun J, Zhao Y, Tang D. Focus on Characteristics of COVID-19 with the Special Reference to the Impact of COVID-19 on the Urogenital System. Curr Urol 2020;14:79-84. [PMID: 32774232 DOI: 10.1159/000499255] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
348 Gan R, Rosoman NP, Henshaw DJE, Noble EP, Georgius P, Sommerfeld N. COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease. Med Hypotheses 2020;144:110024. [PMID: 32758871 DOI: 10.1016/j.mehy.2020.110024] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 12.0] [Reference Citation Analysis]
349 Dorjee K, Kim H. Epidemiological Risk Factors Associated with Death and Severe Disease in Patients Suffering From COVID-19: A Comprehensive Systematic Review and Meta-analysis.. [DOI: 10.1101/2020.06.19.20135483] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
350 Joshi K, Kaplan D, Bakar A, Jennings JF, Hayes DA, Mahajan S, Misra N, Mitchell E, Sweberg TM, Taylor MD, Capone CA. Cardiac Dysfunction and Shock in Pediatric Patients With COVID-19. JACC Case Rep 2020;2:1267-70. [PMID: 32835268 DOI: 10.1016/j.jaccas.2020.05.082] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
351 Gill GS, Vlacancich R, Mehta N, Chaturvedi M, Papolos A. Spectrum of Cardiac Involvement in COVID-19. Cureus 2020;12:e8638. [PMID: 32685307 DOI: 10.7759/cureus.8638] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
352 Deev RV. Cell transplantation for COVID-19 treatment: transmission of stem stomal (mesenchimal) cells. Genes & Cells 2020;15:10-19. [DOI: 10.23868/202004012] [Reference Citation Analysis]
353 Judson GL, Kelemen BW, Njoroge JN, Mahadevan VS. Cardiovascular Implications and Therapeutic Considerations in COVID-19 Infection. Cardiol Ther 2020;9:293-305. [PMID: 32535752 DOI: 10.1007/s40119-020-00184-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
354 Goha A, Mezue K, Edwards P, Nunura F, Baugh D, Madu E. COVID-19 and the heart: An update for clinicians. Clin Cardiol 2020;43:1216-22. [PMID: 32533585 DOI: 10.1002/clc.23406] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
355 Blagosklonny MV. From causes of aging to death from COVID-19. Aging (Albany NY) 2020;12:10004-21. [PMID: 32534452 DOI: 10.18632/aging.103493] [Cited by in Crossref: 63] [Cited by in F6Publishing: 71] [Article Influence: 21.0] [Reference Citation Analysis]
356 Wood TR, Jóhannsson GF. Metabolic health and lifestyle medicine should be a cornerstone of future pandemic preparedness. Lifestyle Medicine 2020;1. [DOI: 10.1002/lim2.2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
357 Madeddu P. Cardiovascular complications of COVID-19: evidence, misconceptions, and new opportunities. Vasc Biol 2020;2:E3-6. [PMID: 32923968 DOI: 10.1530/VB-20-0008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
358 Ponti G, Maccaferri M, Ruini C, Tomasi A, Ozben T. Biomarkers associated with COVID-19 disease progression. Crit Rev Clin Lab Sci 2020;57:389-99. [PMID: 32503382 DOI: 10.1080/10408363.2020.1770685] [Cited by in Crossref: 311] [Cited by in F6Publishing: 251] [Article Influence: 103.7] [Reference Citation Analysis]
359 Baj J, Karakuła-Juchnowicz H, Teresiński G, Buszewicz G, Ciesielka M, Sitarz E, Forma A, Karakuła K, Flieger W, Portincasa P, Maciejewski R. COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge. J Clin Med 2020;9:E1753. [PMID: 32516940 DOI: 10.3390/jcm9061753] [Cited by in Crossref: 161] [Cited by in F6Publishing: 178] [Article Influence: 53.7] [Reference Citation Analysis]
360 Tlegenova Z, Zholdin B, Kurmangazin M, Khamidulla B, Zhailybaev Z. Severe bradyarrhythmia requiring temporary pacemaker in a COVID-19 patient receiving lopinavir/ritonavir treatment: a case report. HVT 2020;4:79. [DOI: 10.24969/hvt.2020.198] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
361 Cormican DS, Winter D, McHugh S, Sonny A, Crowley J, Yu R, Barrack F, Núñez-Gil IJ, Ramakrishna H. Severe Acute Respiratory Syndrome Coronavirus-2 Cardiovascular Complications: Implications for Cardiothoracic Anesthesiology. J Cardiothorac Vasc Anesth 2021;35:932-43. [PMID: 32601001 DOI: 10.1053/j.jvca.2020.05.035] [Reference Citation Analysis]
362 Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodríguez L. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev 2020;54:62-75. [PMID: 32513566 DOI: 10.1016/j.cytogfr.2020.06.001] [Cited by in Crossref: 552] [Cited by in F6Publishing: 590] [Article Influence: 184.0] [Reference Citation Analysis]
363 Barrios-lópez J, Rego-garcía I, Muñoz Martínez C, Romero-fábrega J, Rivero Rodríguez M, Ruiz Giménez J, Escamilla-sevilla F, Mínguez-castellanos A, Fernández Pérez M. Ischaemic stroke and SARS-CoV-2 infection: a causal or incidental association? Neurología (English Edition) 2020;35:295-302. [DOI: 10.1016/j.nrleng.2020.05.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
364 Pirzada A, Mokhtar AT, Moeller AD. COVID-19 and Myocarditis: What Do We Know So Far? CJC Open 2020;2:278-85. [PMID: 32691024 DOI: 10.1016/j.cjco.2020.05.005] [Cited by in Crossref: 69] [Cited by in F6Publishing: 55] [Article Influence: 23.0] [Reference Citation Analysis]
365 Estrada E. Analyzing the impact of SARS CoV-2 on the human proteome.. [DOI: 10.1101/2020.05.21.107912] [Reference Citation Analysis]
366 Hinterseer M, Zens M, Wimmer RJ, Delladio S, Lederle S, Kupatt C, Hartmann B. Acute myocardial infarction due to coronary stent thrombosis in a symptomatic COVID-19 patient. Clin Res Cardiol 2021;110:302-6. [PMID: 32430631 DOI: 10.1007/s00392-020-01663-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
367 Tsai ST, Lu MK, San S, Tsai CH. The Neurologic Manifestations of Coronavirus Disease 2019 Pandemic: A Systemic Review. Front Neurol. 2020;11:498. [PMID: 32574246 DOI: 10.3389/fneur.2020.00498] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 18.7] [Reference Citation Analysis]
368 Harikrishnan S, Mohanan PP, Chopra VK, Ambuj R, Sanjay G, Bansal M, Chakraborty RN, Chandra S, Chattarjee SS, Chopra HK, Mathew C, Deb PK, Goyal A, Goswami KC, Gupta R, Guha S, Gupta V, Hasija PK, Wardhan H, Jabir A, Jayagopal PB, Kahali D, Katyal VK, Kerkar PG, Khanna NN, Majumder B, Mandal M, Meena CB, Naik N, Narain VK, Pathak LA, Ray S, Roy D, Routray SN, Sarma D, Shanmugasundaram S, Singh BP, Tyagi SK, Venugopal K, Wander GS, Yadav R, Das MK. Cardiological society of India position statement on COVID-19 and heart failure. Indian Heart J 2020;72:75-81. [PMID: 32405088 DOI: 10.1016/j.ihj.2020.04.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
369 Singh S, Chakravarty T, Chen P, Akhmerov A, Falk J, Friedman O, Zaman T, Ebinger JE, Gheorghiu M, Marbán L, Marbán E, Makkar RR. Allogeneic cardiosphere-derived cells (CAP-1002) in critically ill COVID-19 patients: compassionate-use case series. Basic Res Cardiol 2020;115:36. [PMID: 32399655 DOI: 10.1007/s00395-020-0795-1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 12.3] [Reference Citation Analysis]
370 Miossec P. Understanding the cytokine storm during COVID-19: Contribution of preexisting chronic inflammation. Eur J Rheumatol 2020;7:S97-8. [PMID: 32412405 DOI: 10.5152/eurjrheum.2020.2062] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
371 Pallarés Carratalá V, Górriz-Zambrano C, Morillas Ariño C, Llisterri Caro JL, Gorriz JL. [COVID-19 and cardiovascular and kidney disease: Where are we? Where are we going?]. Semergen 2020;46 Suppl 1:78-87. [PMID: 32448633 DOI: 10.1016/j.semerg.2020.05.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
372 Salamanca J, Díez-Villanueva P, Martínez P, Cecconi A, González de Marcos B, Reyes G, Salas C, Segovia J, Jiménez-Borreguero LJ, Alfonso F. COVID-19 "Fulminant Myocarditis" Successfully Treated With Temporary Mechanical Circulatory Support. JACC Cardiovasc Imaging 2020;13:2457-9. [PMID: 32713771 DOI: 10.1016/j.jcmg.2020.05.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
373 Barrios-López JM, Rego-García I, Muñoz Martínez C, Romero-Fábrega JC, Rivero Rodríguez M, Ruiz Giménez JA, Escamilla-Sevilla F, Mínguez-Castellanos A, Fernández Pérez MD. Ischaemic stroke and SARS-CoV-2 infection: A causal or incidental association? Neurologia (Engl Ed) 2020;35:295-302. [PMID: 32448674 DOI: 10.1016/j.nrl.2020.05.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
374 Figueira Gonçalves JM, Golpe R. [Clinical challenges in chronic obstructive pulmonary disease in patients who suffered SARS-CoV-2 infection]. Med Clin (Barc) 2020;155:162-4. [PMID: 32475616 DOI: 10.1016/j.medcli.2020.04.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
375 Buja LM, Wolf DA, Zhao B, Akkanti B, McDonald M, Lelenwa L, Reilly N, Ottaviani G, Elghetany MT, Trujillo DO, Aisenberg GM, Madjid M, Kar B. The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities. Cardiovasc Pathol 2020;48:107233. [PMID: 32434133 DOI: 10.1016/j.carpath.2020.107233] [Cited by in Crossref: 263] [Cited by in F6Publishing: 219] [Article Influence: 87.7] [Reference Citation Analysis]
376 Giudicessi JR, Roden DM, Wilde AAM, Ackerman MJ. Genetic susceptibility for COVID-19-associated sudden cardiac death in African Americans. Heart Rhythm 2020;17:1487-92. [PMID: 32380288 DOI: 10.1016/j.hrthm.2020.04.045] [Cited by in Crossref: 54] [Cited by in F6Publishing: 43] [Article Influence: 18.0] [Reference Citation Analysis]
377 Verdecchia P, Cavallini C, Spanevello A, Angeli F. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med. 2020;76:14-20. [PMID: 32336612 DOI: 10.1016/j.ejim.2020.04.037] [Cited by in Crossref: 718] [Cited by in F6Publishing: 764] [Article Influence: 239.3] [Reference Citation Analysis]
378 Ocampo-valencia DBP, Garza-benavides G, Portela-ortiz JM. Manejo perioperatorio del paciente con COVID-19 con afección cardíaca, renal y neurológica. Revista Mexicana de Anestesiología 2020;43:241-244. [DOI: 10.35366/94935] [Reference Citation Analysis]
379 Kim IC, Kim HA, Park JS, Nam CW. Updates of Cardiovascular Manifestations in COVID-19: Korean Experience to Broaden Worldwide Perspectives. Korean Circ J 2020;50:543-54. [PMID: 32588565 DOI: 10.4070/kcj.2020.0205] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
380 Nava-santana, Rodríguez-armida M. Afección extrapulmonar en COVID-19. ¿Estamos ante la nueva y enésima gran imitadora? Revista Mexicana de Trasplantes 2020;9:167-172. [DOI: 10.35366/94506] [Reference Citation Analysis]
381 Zhyvotovska A, Yusupov D, Foronjy R, Nakeshbandi M, McFarlane SI, Salifu M. Insights into Potential Mechanisms of Injury and Treatment Targets in COVID-19, SARS-Cov-2 Infection. Int J Clin Res Trials 2020;5:147. [PMID: 32676542 DOI: 10.15344/2456-8007/2020/147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
382 El-sayyad HI, Abdalhafid YK. COVID-19;-The origin, genetics,and management of the infection of mothers and babies. Egyptian Journal of Basic and Applied Sciences 2020;7:371-388. [DOI: 10.1080/2314808x.2020.1843119] [Reference Citation Analysis]
383 Rozado J, Ayesta A, Morís C, Avanzas P. Fisiopatología de la enfermedad cardiovascular en pacientes con COVID-19. Isquemia, trombosis y disfunción cardiaca. Revista Española de Cardiología Suplementos 2020;20:2-8. [DOI: 10.1016/s1131-3587(20)30028-5] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
384 Papathanassoglou E, Pohar Manhas K, Kusi-appiah E. Beyond Acute Respiratory Distress: Multiple Organ Effects and Early Rehabilitation in COVID-19. sgrwfccn 2019;13:155-161. [DOI: 10.1891/wfccn-d-20-00008] [Reference Citation Analysis]